data_6wqr_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6wqr _Structure_validation_residue.Date_analyzed 2020-06-19 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 96.1 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 120.501 0.191 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -60.1 -52.54 64.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.853 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -93.96 101.98 14.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.35 -42.91 95.99 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.72 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -63.66 -18.91 64.45 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.983 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.48 -36.42 78.92 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.053 0.93 . . . . 0.0 108.501 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -82.45 -43.5 17.18 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.805 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.71 -131.31 9.26 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.02 106.74 16.81 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.1 0.45 . . . . 0.0 110.746 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.401 ' C ' HD22 ' A' ' 12' ' ' LEU . 87.7 t80 53.32 94.46 0.02 OUTLIER 'General case' 0 C--O 1.246 0.89 0 C-N-CA 125.323 1.449 . . . . 0.0 113.899 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.8 mm? -131.8 163.35 28.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -99.49 129.79 45.69 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.6 m -100.34 126.95 46.75 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 122.363 1.077 . . . . 0.0 111.475 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tt -128.21 100.13 5.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.536 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 59.89 34.54 21.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.856 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.58 -10.18 60.89 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.153 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.53 122.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.2 m -87.62 109.98 20.06 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.17 152.77 43.99 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.445 -1.362 0 C-N-CA 121.221 1.281 . . . . 0.0 109.898 175.351 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -96.81 -21.87 17.27 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.836 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.63 95.2 3.55 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.739 0.781 . . . . 0.0 109.115 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.481 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.9 t80 -61.89 -46.42 89.47 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.458 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -65.69 -19.97 66.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.15 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.35 -18.33 60.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 109.703 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.9 m -100.5 4.92 43.98 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.154 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.41 -147.22 17.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.707 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.82 128.66 56.5 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 122.384 0.273 . . . . 0.0 110.395 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.481 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 47.0 t80 54.09 99.48 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.051 1.74 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -132.59 156.56 46.67 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 130.48 56.39 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -101.38 137.81 39.22 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.9 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 tp -153.31 122.77 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 65.57 20.91 11.7 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.731 1.213 . . . . 0.0 110.953 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.34 -3.81 82.23 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.957 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.65 132.06 40.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.55 116.31 22.51 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.49 121.24 34.91 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.368 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.446 -1.314 0 C-N-CA 122.229 1.952 . . . . 0.0 110.816 173.874 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.45 ' HB3' ' OE2' ' A' ' 7' ' ' GLU . 34.9 m . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.09 -48.51 17.6 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.937 -173.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 7' ' ' GLU . 70.1 mm-40 -122.95 160.2 26.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.79 -45.72 34.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.291 1.043 . . . . 0.0 108.478 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.8 p-90 -68.38 -9.8 50.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.439 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.45 ' OE2' ' HB3' ' A' ' 2' ' ' CYS . 42.2 tt0 -63.95 -36.99 85.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.831 0.824 . . . . 0.0 109.003 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 72.5 m -92.82 -43.83 8.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.995 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.26 177.62 14.96 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.869 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.62 122.42 19.06 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 68.42 16.0 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.491 1.116 . . . . 0.0 112.737 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -103.53 102.67 12.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.95 168.9 11.08 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.44 128.84 47.47 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.14 111.99 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 65.62 21.57 11.68 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 126.649 1.979 . . . . 0.0 111.003 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.38 -2.47 74.37 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.961 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.93 137.49 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 38.0 m -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -140.41 153.05 68.15 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 C-N-CA 121.629 1.553 . . . . 0.0 109.425 175.266 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.2 m . . . . . 0 N--CA 1.439 -0.992 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.49 -55.66 2.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -135.68 104.69 5.87 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.39 -48.09 83.25 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.66 0.743 . . . . 0.0 110.336 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -61.89 -27.07 68.55 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.165 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -71.58 -30.74 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.1 0.953 . . . . 0.0 109.693 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.16 -42.57 10.98 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.718 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.51 -177.37 16.51 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.93 140.91 29.94 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 72.89 16.82 4.41 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.07 145.93 28.99 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -111.93 141.76 45.17 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.03 127.79 47.38 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-O 122.085 0.945 . . . . 0.0 110.807 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -135.83 114.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 66.65 24.48 10.07 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 125.401 1.481 . . . . 0.0 110.85 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.46 0.46 89.37 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.109 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.6 mt -105.42 139.38 26.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.12 114.46 25.73 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.979 0.419 . . . . 0.0 110.327 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.09 133.68 23.4 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--O 1.241 0.625 0 C-N-CA 122.009 1.806 . . . . 0.0 109.816 174.807 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.245 0.834 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -105.03 -56.17 2.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.947 0.403 . . . . 0.0 111.2 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -121.41 130.27 53.5 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.262 0.553 . . . . 0.0 110.692 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -63.61 -45.31 90.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.777 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -68.06 -16.76 64.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.175 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.08 -32.82 71.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.67 0.748 . . . . 0.0 109.123 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.3 m -85.03 -37.59 20.18 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.906 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.85 -60.3 0.57 Allowed Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.6 174.87 5.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -74.13 99.13 3.29 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.487 1.137 . . . . 0.0 111.2 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.4 tp -129.37 156.19 44.45 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.394 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.7 141.92 32.06 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.687 0.28 . . . . 0.0 110.468 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -106.69 130.87 54.35 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.409 0.623 . . . . 0.0 109.851 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 112.08 20.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 63.44 24.04 13.96 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.562 1.145 . . . . 0.0 112.77 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.59 75.25 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.426 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mt -106.4 127.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.3 m -83.17 112.3 19.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.63 138.01 31.67 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--O 1.253 1.243 0 C-N-CA 122.257 1.971 . . . . 0.0 110.268 174.433 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -72.3 -56.16 5.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.46 124.24 19.86 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -56.08 -52.46 64.22 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 123.664 0.786 . . . . 0.0 110.841 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -63.55 -17.07 62.43 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 124.648 1.179 . . . . 0.0 113.448 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.68 -22.46 56.67 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.804 0.812 . . . . 0.0 109.739 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.1 m -120.23 -42.68 2.56 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.574 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.65 -161.66 12.63 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.62 155.07 18.08 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 122.521 0.328 . . . . 0.0 110.249 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 68.83 14.01 8.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.37 140.74 32.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.85 107.54 18.73 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 67.7 m -101.35 141.76 33.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.705 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 tt -144.73 114.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 64.83 22.57 12.54 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.973 1.309 . . . . 0.0 111.899 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.49 -18.0 49.09 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.976 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 46.5 mm -85.95 130.51 36.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 m -96.49 111.15 23.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.63 115.23 60.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.108 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 N--CA 1.443 -1.48 0 N-CA-C 107.718 -1.685 . . . . 0.0 107.718 170.554 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 46.2 m . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -97.89 -55.42 2.8 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.46 82.72 1.64 Allowed 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 122.849 1.309 . . . . 0.0 111.653 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.13 -40.89 82.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.842 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -63.8 -22.85 67.11 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.565 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -91.11 -17.97 25.29 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.943 0.877 . . . . 0.0 109.594 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.83 -38.7 11.61 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.068 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.7 171.95 14.18 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.3 36.02 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.457 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 72.86 28.14 2.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.035 1.334 . . . . 0.0 112.158 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.33 119.35 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.425 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -95.17 156.38 16.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.38 152.92 31.97 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.487 0.661 . . . . 0.0 112.782 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 67.1 mt -143.0 119.13 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 36.1 mt-10 71.33 11.1 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.274 1.43 . . . . 0.0 111.349 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.23 70.57 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.9 mt -97.0 126.74 49.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.4 m -80.89 116.36 20.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.96 131.09 22.39 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-O 121.213 0.53 . . . . 0.0 111.768 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.439 -1.691 0 C-N-CA 122.168 1.912 . . . . 0.0 110.685 172.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.239 0.545 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -106.07 -55.69 2.29 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.944 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -134.33 112.54 11.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.692 0.797 . . . . 0.0 109.524 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -63.3 -42.99 99.09 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.47 1.108 . . . . 0.0 111.366 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -59.92 -26.66 66.12 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.385 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.23 -19.64 42.75 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.705 0.802 . . . . 0.0 111.513 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.7 m -100.68 -39.35 7.9 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.786 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.41 -140.37 11.81 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.401 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.57 118.73 35.89 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.635 0.217 . . . . 0.0 111.231 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 47.72 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.503 1.521 . . . . 0.0 112.724 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -118.5 163.61 16.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.645 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -102.57 115.42 30.55 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 m -101.63 132.25 47.41 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.44 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.5 tt -131.4 105.82 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 CA-C-O 121.895 0.855 . . . . 0.0 109.746 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 65.01 21.02 12.24 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.859 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.13 -8.07 41.45 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.912 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.48 119.4 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -92.89 118.85 31.59 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.4 153.81 38.81 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 N--CA 1.459 -0.502 0 C-N-CA 121.992 1.795 . . . . 0.0 110.289 178.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -96.99 -56.35 2.58 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.948 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.17 97.77 8.55 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.88 -52.24 60.88 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.941 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -57.34 -25.16 58.96 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 126.425 1.89 . . . . 0.0 113.234 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -70.6 -30.56 67.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.297 1.046 . . . . 0.0 109.444 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 64.3 m -97.98 -42.34 7.56 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.607 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.6 -173.32 20.15 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.81 33.7 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.712 0.292 . . . . 0.0 110.916 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 69.39 23.59 6.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.219 1.408 . . . . 0.0 112.016 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.33 118.3 23.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.564 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.5 m -100.8 140.62 34.82 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 tt -126.76 109.78 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 70.88 19.4 5.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.442 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 -20.91 45.65 Favored Glycine 0 C--O 1.236 0.226 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.11 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.19 127.81 41.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 m -81.99 109.64 16.51 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -101.32 126.05 35.82 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo . . . . . 0 C--N 1.36 1.162 0 C-N-CA 123.385 2.723 . . . . 0.0 111.164 178.134 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -80.05 -55.96 4.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.262 0.553 . . . . 0.0 109.556 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -136.2 106.09 6.25 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.167 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.29 -46.81 85.02 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.17 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -60.19 -29.65 68.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.823 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.34 -44.4 75.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.63 0.729 . . . . 0.0 109.922 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.5 m -77.48 -39.57 46.0 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.804 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.36 165.34 12.06 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.41 142.86 35.57 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 69.12 25.25 5.84 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.545 1.138 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.33 149.61 22.25 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.4 143.18 45.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.3 m -106.54 133.54 51.07 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.393 0.616 . . . . 0.0 110.624 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 tt -145.31 114.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 63.28 23.47 13.83 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.753 1.221 . . . . 0.0 112.106 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.99 69.92 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -100.55 124.09 53.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -89.6 109.96 20.87 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.86 129.28 6.77 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 N--CA 1.444 -1.41 0 C-N-CA 122.11 1.873 . . . . 0.0 111.408 -179.017 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.5 m . . . . . 0 C--O 1.237 0.447 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.468 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 34.9 mtmm -79.95 -55.5 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 45.0 mm-40 -117.57 156.27 28.38 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -70.44 -59.09 3.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.772 0.796 . . . . 0.0 111.394 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -60.94 -15.19 28.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.602 1.161 . . . . 0.0 112.646 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE2' ' HB2' ' A' ' 3' ' ' LYS . 31.7 tt0 -55.68 -41.62 73.97 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 124.841 1.257 . . . . 0.0 110.334 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.0 m -106.55 -30.46 9.03 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.536 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.95 -165.47 12.04 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.85 132.53 33.8 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 120.644 0.259 . . . . 0.0 111.096 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 70.04 16.42 7.55 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.142 1.377 . . . . 0.0 114.549 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.94 142.57 27.89 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -95.34 115.65 27.71 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.4 m -100.42 126.66 46.84 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.3 -175.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.3 mt -113.19 104.84 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.569 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 65.44 25.13 11.94 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 125.486 1.514 . . . . 0.0 111.854 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.2 -8.75 57.46 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.214 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 81.3 mt -92.01 134.17 31.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.39 114.9 22.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.228 0.537 . . . . 0.0 109.934 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.96 144.84 44.1 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 C--O 1.247 0.94 0 C-N-CA 122.108 1.872 . . . . 0.0 111.335 175.008 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -78.14 -55.82 4.96 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.408 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.35 140.12 39.33 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -54.61 -52.73 61.3 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.322 1.449 . . . . 0.0 111.258 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -63.54 -23.77 67.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.604 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.93 -26.89 62.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.155 0.979 . . . . 0.0 109.831 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 58.5 m -102.34 5.04 39.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.399 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.24 -81.56 1.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.71 175.83 5.27 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.98 118.3 7.62 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 33.0 tp -136.66 162.36 33.38 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -82.66 137.42 34.48 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 57.3 m -114.07 142.36 46.29 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.72 110.51 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 62.61 25.79 15.32 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.63 -15.05 56.18 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.083 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 70.9 mt -89.26 117.42 32.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.75 109.23 15.96 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.85 125.31 38.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo . . . . . 0 C--N 1.353 0.815 0 C-N-CA 123.659 2.906 . . . . 0.0 111.683 177.104 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 84.9 m . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.33 -54.14 7.58 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -82.14 95.92 7.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -74.63 -44.14 51.98 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.925 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -59.93 -25.63 65.32 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.099 -1.41 . . . . 0.0 112.268 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.78 -18.5 64.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.788 0.804 . . . . 0.0 110.312 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 59.6 m -98.02 -1.59 42.25 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.79 -149.12 29.57 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.216 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.58 111.33 22.89 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.803 0.302 . . . . 0.0 111.518 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 50.01 80.89 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.14 1.376 . . . . 0.0 113.772 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 17.0 tp -131.07 136.88 48.82 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 86.9 m-85 -82.75 154.75 24.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.487 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.4 m -100.97 132.12 46.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.7 mm -137.69 117.53 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 65.93 19.52 11.26 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 125.404 1.482 . . . . 0.0 112.074 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.7 -8.9 60.14 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.491 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.7 mt -115.54 145.44 21.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 67.4 m -83.89 129.49 34.93 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.121 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.03 141.04 20.55 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--O 1.24 0.622 0 C-N-CA 122.25 1.967 . . . . 0.0 112.657 178.888 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -75.14 -55.24 5.93 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.026 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.76 107.23 7.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.1 t80 -62.3 -45.49 92.99 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.984 -175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -57.7 -34.32 69.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.393 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.97 -28.42 64.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.577 0.751 . . . . 0.0 111.065 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -74.95 -18.49 60.38 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.268 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 -157.35 16.55 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.35 113.92 27.02 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.598 0.199 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.401 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 76.6 t80 63.92 95.45 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.106 1.362 . . . . 0.0 113.724 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -132.73 160.44 36.8 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -106.64 149.8 26.85 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.1 m -101.14 132.87 46.41 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 120.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.77 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.345 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 68.22 19.99 8.95 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.643 1.577 . . . . 0.0 111.187 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.37 6.19 74.6 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.7 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.04 144.32 23.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.0 m -83.05 109.78 17.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.92 134.89 25.7 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo . . . . . 0 N--CA 1.454 -0.83 0 C-N-CA 121.673 1.582 . . . . 0.0 110.155 173.771 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.443 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 60.7 m . . . . . 0 C--O 1.243 0.72 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.46 ' HB2' ' HZ3' ' A' ' 3' ' ' LYS . 9.7 mtmp? -57.28 -56.17 25.35 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.9 80.92 1.43 Allowed 'General case' 0 N--CA 1.414 -2.269 0 CA-C-O 122.816 1.293 . . . . 0.0 111.545 177.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -64.49 -45.69 86.21 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.853 -174.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -65.43 -25.34 67.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.137 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -84.07 -50.98 7.47 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.538 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 54.5 m -71.96 -42.96 65.94 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.626 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.51 159.3 25.77 Favored Glycine 0 C--O 1.254 1.392 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.577 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.94 4.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.942 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 179.22 -32.36 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 125.192 1.397 . . . . 0.0 107.501 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.02 149.32 27.03 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.036 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.49 146.34 24.16 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.1 m -101.36 120.73 40.72 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -132.88 111.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 65.84 22.63 11.42 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.266 1.426 . . . . 0.0 111.04 -176.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.79 -6.77 83.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.807 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.82 135.73 25.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 2' ' ' CYS . 20.1 m -82.02 110.0 16.87 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.38 152.08 77.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.412 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo . . . . . 0 N--CA 1.45 -1.08 0 C-N-CA 121.872 1.714 . . . . 0.0 108.372 170.835 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -77.9 -55.21 5.5 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.49 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -118.45 141.86 48.14 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.12 -48.76 6.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -50.28 -44.66 53.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.53 1.532 . . . . 0.0 113.638 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.58 -26.15 63.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.124 0.964 . . . . 0.0 110.596 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 59.4 m -92.64 -30.68 15.47 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.005 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.32 -146.48 18.15 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.38 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.49 122.04 46.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 60.42 101.01 0.02 OUTLIER 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.84 1.256 . . . . 0.0 111.135 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.485 HD21 ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -135.36 162.95 31.16 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.356 -175.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.66 141.68 44.96 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.485 ' SG ' HD21 ' A' ' 12' ' ' LEU . 76.0 m -116.66 138.35 51.51 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.64 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.43 106.03 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.184 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 63.34 26.32 14.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.187 1.395 . . . . 0.0 112.317 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.66 -17.77 57.05 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.376 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.38 132.27 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 m -98.92 150.02 22.35 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.029 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.03 120.17 30.44 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.461 2.108 . . . . 0.0 113.277 -176.57 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.4 -55.39 4.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -104.63 89.43 3.19 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -79.09 -38.74 35.52 Favored 'General case' 0 C--N 1.261 -3.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.962 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -52.81 -33.91 51.35 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.783 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.28 -31.33 65.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.613 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.2 m -81.35 -41.26 22.28 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.39 161.53 14.57 Favored Glycine 0 N--CA 1.417 -2.575 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.058 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.52 126.28 28.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 80.8 7.57 1.3 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.119 1.368 . . . . 0.0 113.165 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.4 tp -94.31 101.78 13.75 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.7 153.79 25.15 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.268 -171.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 56.6 m -100.13 127.87 46.3 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -124.64 110.45 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 67.87 23.06 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.704 1.602 . . . . 0.0 109.8 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.29 -20.52 42.41 Favored Glycine 0 C--N 1.309 -0.965 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.022 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 48.3 mm -96.19 138.69 20.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.0 m -81.16 108.99 15.28 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.05 125.16 30.69 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.516 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.448 -1.156 0 C-N-CA 122.127 1.884 . . . . 0.0 111.102 175.868 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.505 -0.778 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.96 -42.11 9.64 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 40.5 mt-10 -107.75 115.63 30.5 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -53.9 -49.56 68.33 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.869 0.842 . . . . 0.0 111.166 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.474 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 37.7 p90 -63.4 -9.88 14.37 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.945 -1.48 . . . . 0.0 114.349 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.63 -56.7 12.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.552 0.691 . . . . 0.0 110.818 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.48 -25.83 5.93 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.222 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.13 152.64 15.25 Favored Glycine 0 C--O 1.247 0.925 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.72 93.61 8.48 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.606 0.717 . . . . 0.0 110.6 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -172.96 -45.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.45 162.9 17.02 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 71.3 m-85 -98.32 168.76 10.02 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 m -138.61 120.42 15.34 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.348 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 tt -98.28 91.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 CA-C-O 122.786 1.279 . . . . 0.0 108.234 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.19 28.09 17.64 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.514 -2.13 . . . . 0.0 112.056 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.99 -16.01 23.18 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.443 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 50.9 mm -86.74 133.49 29.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -81.76 131.28 35.26 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.06 0.457 . . . . 0.0 110.355 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 13' ' ' PHE . 61.6 t -99.74 123.44 47.68 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 C--O 1.245 0.867 0 C-N-CA 123.543 2.829 . . . . 0.0 113.979 -176.626 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 C--O 1.246 0.88 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -56.9 -39.55 74.61 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.506 ' HB3' ' HG2' ' A' ' 7' ' ' GLU . 9.4 tp10 -165.79 146.6 6.84 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 168.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -77.92 -53.28 7.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.577 0.703 . . . . 0.0 111.547 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -68.82 -26.19 65.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 9.4 pt-20 -72.16 -27.68 62.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.401 0.62 . . . . 0.0 110.868 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.2 m -83.57 -39.4 20.42 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.507 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.29 -146.25 18.21 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.3 122.37 46.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 57.29 82.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.906 1.282 . . . . 0.0 114.088 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.65 131.62 53.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.43 118.08 24.74 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 60.2 m -100.83 144.87 29.26 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.831 -171.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.2 mt -139.5 121.3 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 68.59 22.18 7.71 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.397 1.479 . . . . 0.0 109.772 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -15.98 59.89 Favored Glycine 0 C--N 1.305 -1.158 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.705 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.42 131.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 58.0 m -81.36 109.63 16.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.58 110.76 62.66 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.144 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 N--CA 1.432 -2.137 0 C-N-CA 121.766 1.644 . . . . 0.0 110.999 176.849 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 80.3 m . . . . . 0 C--O 1.241 0.626 0 CA-C-O 120.491 0.186 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -79.75 -33.49 40.68 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.286 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -73.8 78.37 1.59 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.325 1.06 . . . . 0.0 112.055 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -72.17 -44.1 63.57 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.09 -1.413 . . . . 0.0 108.251 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -60.05 -35.05 74.28 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.59 -49.41 12.23 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.23 -42.24 55.74 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.075 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.09 -170.43 15.03 Favored Glycine 0 C--N 1.299 -1.499 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 95.16 1.47 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 60.47 85.77 0.11 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.38 156.47 23.4 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -100.12 163.75 12.28 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.6 m -123.33 137.6 54.8 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.162 -1.015 . . . . 0.0 113.507 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.27 105.03 13.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 66.34 22.12 10.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 126.314 1.845 . . . . 0.0 110.534 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.82 -7.55 63.06 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.918 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mm -87.08 125.41 40.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.3 m -81.3 121.6 26.39 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.461 0.476 . . . . 0.0 110.261 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.54 160.09 66.6 Favored Pre-proline 0 C--N 1.305 -1.339 0 C-N-CA 124.033 0.933 . . . . 0.0 108.987 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--O 1.243 0.77 0 C-N-CA 121.483 1.456 . . . . 0.0 109.022 170.583 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 CA--C 1.517 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -77.56 -42.62 34.67 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -89.88 88.25 7.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.254 176.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 26.3 t80 -85.2 -27.81 25.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -61.18 -25.25 66.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.646 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.35 -33.14 69.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.95 0.881 . . . . 0.0 109.484 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.3 m -76.19 -43.42 42.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.527 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.76 -148.1 18.91 Favored Glycine 0 C--N 1.298 -1.53 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.42 105.91 17.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.065 -178.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 97.7 m-85 65.45 86.61 0.13 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.692 1.197 . . . . 0.0 114.094 175.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 11' ' ' PHE . 3.7 mm? -136.39 162.91 31.73 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.215 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -108.25 154.02 22.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.59 139.22 50.75 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.391 0.615 . . . . 0.0 111.699 -178.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 tt -140.19 108.97 3.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.278 175.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 61.38 26.94 16.64 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.105 1.362 . . . . 0.0 112.071 178.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.81 -9.85 64.13 Favored Glycine 0 C--N 1.313 -0.713 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.187 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.12 128.38 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.0 m -87.59 118.06 26.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.99 140.06 30.27 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.591 -179.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 122.38 2.053 . . . . 0.0 110.958 175.224 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.487 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 96.1 m -58.58 157.32 9.3 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.345 0.658 . . . . 0.0 110.604 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -60.1 -52.54 64.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.853 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -93.96 101.98 14.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.35 -42.91 95.99 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.72 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -63.66 -18.91 64.45 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.983 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.48 -36.42 78.92 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.053 0.93 . . . . 0.0 108.501 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -82.45 -43.5 17.18 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.805 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.71 -131.31 9.26 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.02 106.74 16.81 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.1 0.45 . . . . 0.0 110.746 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' C ' HD22 ' A' ' 12' ' ' LEU . 87.7 t80 53.32 94.46 0.02 OUTLIER 'General case' 0 C--O 1.246 0.89 0 C-N-CA 125.323 1.449 . . . . 0.0 113.899 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.8 mm? -131.8 163.35 28.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -99.49 129.79 45.69 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.6 m -100.34 126.95 46.75 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 122.363 1.077 . . . . 0.0 111.475 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tt -128.21 100.13 5.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.536 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 59.89 34.54 21.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.856 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.58 -10.18 60.89 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.153 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.53 122.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.2 m -87.62 109.98 20.06 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.17 152.77 43.99 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.37 130.96 18.15 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 121.221 1.281 . . . . 0.0 109.898 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.9 ttp -78.25 149.56 33.58 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.005 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mp -97.98 -80.43 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.898 0 O-C-N 122.22 -0.3 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 69.0 m -78.47 130.76 36.42 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -96.81 -21.87 17.27 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.836 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.63 95.2 3.55 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.739 0.781 . . . . 0.0 109.115 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.481 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.9 t80 -61.89 -46.42 89.47 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.458 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -65.69 -19.97 66.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.15 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.35 -18.33 60.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 109.703 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.9 m -100.5 4.92 43.98 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.154 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.41 -147.22 17.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.707 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.82 128.66 56.5 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 122.384 0.273 . . . . 0.0 110.395 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.481 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 47.0 t80 54.09 99.48 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.051 1.74 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -132.59 156.56 46.67 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 130.48 56.39 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -101.38 137.81 39.22 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.9 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 tp -153.31 122.77 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 65.57 20.91 11.7 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.731 1.213 . . . . 0.0 110.953 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.34 -3.81 82.23 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.957 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.65 132.06 40.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.55 116.31 22.51 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.49 121.24 34.91 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.368 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -84.84 137.5 6.53 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.229 1.952 . . . . 0.0 110.816 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.07 155.23 27.64 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.0 mt -83.0 -84.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.937 0 O-C-N 122.08 -0.387 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.645 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.45 ' HB3' ' OE2' ' A' ' 7' ' ' GLU . 34.9 m -75.04 170.14 16.6 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.09 -48.51 17.6 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.937 -173.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 7' ' ' GLU . 70.1 mm-40 -122.95 160.2 26.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.79 -45.72 34.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.291 1.043 . . . . 0.0 108.478 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.8 p-90 -68.38 -9.8 50.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.439 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.45 ' OE2' ' HB3' ' A' ' 2' ' ' CYS . 42.2 tt0 -63.95 -36.99 85.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.831 0.824 . . . . 0.0 109.003 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 72.5 m -92.82 -43.83 8.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.995 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.26 177.62 14.96 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.869 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.62 122.42 19.06 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 68.42 16.0 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.491 1.116 . . . . 0.0 112.737 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -103.53 102.67 12.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.95 168.9 11.08 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.44 128.84 47.47 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.14 111.99 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 65.62 21.57 11.68 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 126.649 1.979 . . . . 0.0 111.003 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.38 -2.47 74.37 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.961 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.93 137.49 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 38.0 m -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -140.41 153.05 68.15 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.95 130.98 16.23 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.629 1.553 . . . . 0.0 109.425 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.6 ttt -77.81 140.97 39.46 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 tp -124.65 -62.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.93 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.164 0 O-C-N 121.919 -0.488 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.901 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.2 m -99.78 147.59 25.31 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.49 -55.66 2.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -135.68 104.69 5.87 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.39 -48.09 83.25 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.66 0.743 . . . . 0.0 110.336 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -61.89 -27.07 68.55 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.165 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -71.58 -30.74 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.1 0.953 . . . . 0.0 109.693 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.16 -42.57 10.98 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.718 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.51 -177.37 16.51 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.93 140.91 29.94 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 72.89 16.82 4.41 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.07 145.93 28.99 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -111.93 141.76 45.17 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.03 127.79 47.38 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-O 122.085 0.945 . . . . 0.0 110.807 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -135.83 114.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 66.65 24.48 10.07 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 125.401 1.481 . . . . 0.0 110.85 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.46 0.46 89.37 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.109 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.6 mt -105.42 139.38 26.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.12 114.46 25.73 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.979 0.419 . . . . 0.0 110.327 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.09 133.68 23.4 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.06 129.83 19.08 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 122.009 1.806 . . . . 0.0 109.816 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.6 tpt -102.73 151.51 22.31 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-O 121.032 0.444 . . . . 0.0 110.727 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tt -95.65 93.99 4.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.125 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.576 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.4 m -66.36 142.54 57.59 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 123.233 0.333 . . . . 0.0 110.539 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -105.03 -56.17 2.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.947 0.403 . . . . 0.0 111.2 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -121.41 130.27 53.5 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.262 0.553 . . . . 0.0 110.692 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -63.61 -45.31 90.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.777 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -68.06 -16.76 64.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.175 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.08 -32.82 71.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.67 0.748 . . . . 0.0 109.123 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.3 m -85.03 -37.59 20.18 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.906 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.85 -60.3 0.57 Allowed Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.6 174.87 5.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -74.13 99.13 3.29 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.487 1.137 . . . . 0.0 111.2 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.4 tp -129.37 156.19 44.45 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.394 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.7 141.92 32.06 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.687 0.28 . . . . 0.0 110.468 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -106.69 130.87 54.35 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.409 0.623 . . . . 0.0 109.851 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 112.08 20.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 63.44 24.04 13.96 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.562 1.145 . . . . 0.0 112.77 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.59 75.25 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.426 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mt -106.4 127.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.3 m -83.17 112.3 19.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.63 138.01 31.67 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.73 122.39 11.72 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 122.257 1.971 . . . . 0.0 110.268 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.6 ttt -63.11 143.83 57.44 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.487 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -87.03 -73.94 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.143 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.153 0 O-C-N 122.37 -0.207 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.8 m -100.06 166.68 10.91 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -72.3 -56.16 5.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.46 124.24 19.86 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -56.08 -52.46 64.22 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 123.664 0.786 . . . . 0.0 110.841 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -63.55 -17.07 62.43 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 124.648 1.179 . . . . 0.0 113.448 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.68 -22.46 56.67 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.804 0.812 . . . . 0.0 109.739 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.1 m -120.23 -42.68 2.56 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.574 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.65 -161.66 12.63 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.62 155.07 18.08 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 122.521 0.328 . . . . 0.0 110.249 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 68.83 14.01 8.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.37 140.74 32.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.85 107.54 18.73 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 67.7 m -101.35 141.76 33.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.705 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 tt -144.73 114.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 64.83 22.57 12.54 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.973 1.309 . . . . 0.0 111.899 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.49 -18.0 49.09 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.976 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 46.5 mm -85.95 130.51 36.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 m -96.49 111.15 23.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.63 115.23 60.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.108 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.32 112.26 2.95 Favored 'Trans proline' 0 N--CA 1.443 -1.48 0 N-CA-C 107.718 -1.685 . . . . 0.0 107.718 170.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 54.7 ttp -75.36 138.81 42.01 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 121.236 0.541 . . . . 0.0 110.041 -175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 tp -133.14 105.22 7.77 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.278 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.155 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.455 0 CA-C-N 116.119 -0.491 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.613 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 46.2 m -80.51 129.72 34.69 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -97.89 -55.42 2.8 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.46 82.72 1.64 Allowed 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 122.849 1.309 . . . . 0.0 111.653 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.13 -40.89 82.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.842 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -63.8 -22.85 67.11 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.565 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -91.11 -17.97 25.29 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.943 0.877 . . . . 0.0 109.594 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.83 -38.7 11.61 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.068 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.7 171.95 14.18 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.3 36.02 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.457 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 72.86 28.14 2.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.035 1.334 . . . . 0.0 112.158 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.33 119.35 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.425 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -95.17 156.38 16.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.38 152.92 31.97 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.487 0.661 . . . . 0.0 112.782 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 67.1 mt -143.0 119.13 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 36.1 mt-10 71.33 11.1 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.274 1.43 . . . . 0.0 111.349 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.23 70.57 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.9 mt -97.0 126.74 49.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.4 m -80.89 116.36 20.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.96 131.09 22.39 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-O 121.213 0.53 . . . . 0.0 111.768 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.59 144.44 11.29 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 122.168 1.912 . . . . 0.0 110.685 172.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.4 ttt -83.79 152.52 24.59 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.379 0.609 . . . . 0.0 110.665 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 tp -82.31 96.37 3.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.867 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.242 0 CA-C-N 115.975 -0.557 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 120.529 0.204 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.8 m -97.84 143.99 27.88 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -106.07 -55.69 2.29 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.944 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -134.33 112.54 11.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.692 0.797 . . . . 0.0 109.524 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -63.3 -42.99 99.09 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.47 1.108 . . . . 0.0 111.366 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -59.92 -26.66 66.12 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.385 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.23 -19.64 42.75 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.705 0.802 . . . . 0.0 111.513 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.7 m -100.68 -39.35 7.9 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.786 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.41 -140.37 11.81 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.401 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.57 118.73 35.89 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.635 0.217 . . . . 0.0 111.231 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 47.72 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.503 1.521 . . . . 0.0 112.724 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -118.5 163.61 16.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.645 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -102.57 115.42 30.55 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 m -101.63 132.25 47.41 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.44 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.5 tt -131.4 105.82 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 CA-C-O 121.895 0.855 . . . . 0.0 109.746 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 65.01 21.02 12.24 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.859 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.13 -8.07 41.45 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.912 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.48 119.4 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -92.89 118.85 31.59 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.4 153.81 38.81 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.2 121.97 10.44 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 121.992 1.795 . . . . 0.0 110.289 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.1 tpt -69.51 137.63 52.67 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.607 0.718 . . . . 0.0 110.326 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -104.37 97.96 6.24 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.284 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.25 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.514 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.3 m -75.49 129.5 37.37 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -96.99 -56.35 2.58 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.948 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.17 97.77 8.55 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.88 -52.24 60.88 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.941 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -57.34 -25.16 58.96 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 126.425 1.89 . . . . 0.0 113.234 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -70.6 -30.56 67.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.297 1.046 . . . . 0.0 109.444 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 64.3 m -97.98 -42.34 7.56 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.607 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.6 -173.32 20.15 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.81 33.7 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.712 0.292 . . . . 0.0 110.916 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 69.39 23.59 6.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.219 1.408 . . . . 0.0 112.016 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.33 118.3 23.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.564 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.5 m -100.8 140.62 34.82 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 tt -126.76 109.78 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 70.88 19.4 5.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.442 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 -20.91 45.65 Favored Glycine 0 C--O 1.236 0.226 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.11 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.19 127.81 41.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 m -81.99 109.64 16.51 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -101.32 126.05 35.82 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.21 130.78 33.45 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.385 2.723 . . . . 0.0 111.164 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 33.0 tpp -128.39 156.79 42.58 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.447 HG21 ' HN1' ' A' ' 24' ' ' NH2 . 9.1 tt -118.77 -66.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 123.484 0.49 . . . . 0.0 111.892 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . 0.447 ' HN1' HG21 ' A' ' 23' ' ' ILE . . . . . . . . 0 C--N 1.313 -0.996 0 O-C-N 121.714 -0.616 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.802 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 60.3 m -100.46 137.37 38.97 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -80.05 -55.96 4.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.262 0.553 . . . . 0.0 109.556 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -136.2 106.09 6.25 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.167 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.29 -46.81 85.02 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.17 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -60.19 -29.65 68.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.823 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.34 -44.4 75.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.63 0.729 . . . . 0.0 109.922 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.5 m -77.48 -39.57 46.0 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.804 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.36 165.34 12.06 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.41 142.86 35.57 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 69.12 25.25 5.84 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.545 1.138 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.33 149.61 22.25 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.4 143.18 45.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.3 m -106.54 133.54 51.07 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.393 0.616 . . . . 0.0 110.624 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 tt -145.31 114.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 63.28 23.47 13.83 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.753 1.221 . . . . 0.0 112.106 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.99 69.92 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -100.55 124.09 53.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -89.6 109.96 20.87 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.86 129.28 6.77 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.52 168.76 14.32 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.11 1.873 . . . . 0.0 111.408 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.8 ttp -92.44 152.33 19.75 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 mp -96.04 -78.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.107 0 O-C-N 122.199 -0.313 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . 0 C--O 1.242 0.694 0 CA-C-O 121.336 0.588 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.5 m -88.0 157.26 18.96 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.468 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 34.9 mtmm -79.95 -55.5 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 45.0 mm-40 -117.57 156.27 28.38 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -70.44 -59.09 3.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.772 0.796 . . . . 0.0 111.394 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -60.94 -15.19 28.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.602 1.161 . . . . 0.0 112.646 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE2' ' HB2' ' A' ' 3' ' ' LYS . 31.7 tt0 -55.68 -41.62 73.97 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 124.841 1.257 . . . . 0.0 110.334 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.0 m -106.55 -30.46 9.03 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.536 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.95 -165.47 12.04 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.85 132.53 33.8 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 120.644 0.259 . . . . 0.0 111.096 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 70.04 16.42 7.55 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.142 1.377 . . . . 0.0 114.549 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.94 142.57 27.89 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -95.34 115.65 27.71 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.4 m -100.42 126.66 46.84 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.3 -175.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.3 mt -113.19 104.84 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.569 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 65.44 25.13 11.94 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 125.486 1.514 . . . . 0.0 111.854 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.2 -8.75 57.46 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.214 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 81.3 mt -92.01 134.17 31.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.39 114.9 22.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.228 0.537 . . . . 0.0 109.934 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.96 144.84 44.1 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.91 134.27 63.09 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.108 1.872 . . . . 0.0 111.335 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 53.0 ttm -78.35 145.3 35.32 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.142 0.496 . . . . 0.0 110.286 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -113.93 88.46 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.756 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.563 0 CA-C-N 116.129 -0.487 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.535 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.2 m -94.37 144.01 25.91 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -78.14 -55.82 4.96 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.408 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.35 140.12 39.33 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -54.61 -52.73 61.3 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.322 1.449 . . . . 0.0 111.258 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -63.54 -23.77 67.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.604 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.93 -26.89 62.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.155 0.979 . . . . 0.0 109.831 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 58.5 m -102.34 5.04 39.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.399 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.24 -81.56 1.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.71 175.83 5.27 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.98 118.3 7.62 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 33.0 tp -136.66 162.36 33.38 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -82.66 137.42 34.48 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 57.3 m -114.07 142.36 46.29 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.72 110.51 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 62.61 25.79 15.32 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.63 -15.05 56.18 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.083 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 70.9 mt -89.26 117.42 32.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.75 109.23 15.96 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.85 125.31 38.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.62 135.55 56.14 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.659 2.906 . . . . 0.0 111.683 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 53.0 ttp -69.35 144.34 53.48 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.285 0.564 . . . . 0.0 109.719 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.4 mm -98.76 97.73 6.34 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.146 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 CA-C-N 116.463 -0.335 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 120.53 0.205 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 84.9 m -70.96 131.78 44.22 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.33 -54.14 7.58 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -82.14 95.92 7.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -74.63 -44.14 51.98 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.925 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -59.93 -25.63 65.32 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.099 -1.41 . . . . 0.0 112.268 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.78 -18.5 64.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.788 0.804 . . . . 0.0 110.312 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 59.6 m -98.02 -1.59 42.25 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.79 -149.12 29.57 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.216 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.58 111.33 22.89 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.803 0.302 . . . . 0.0 111.518 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 50.01 80.89 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.14 1.376 . . . . 0.0 113.772 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 17.0 tp -131.07 136.88 48.82 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 86.9 m-85 -82.75 154.75 24.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.487 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.4 m -100.97 132.12 46.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.7 mm -137.69 117.53 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 65.93 19.52 11.26 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 125.404 1.482 . . . . 0.0 112.074 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.7 -8.9 60.14 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.491 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.7 mt -115.54 145.44 21.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 67.4 m -83.89 129.49 34.93 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.121 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.03 141.04 20.55 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.99 143.62 66.7 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.25 1.967 . . . . 0.0 112.657 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.67 139.91 31.7 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -104.08 93.54 2.68 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.885 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.159 -173.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.565 0 CA-C-N 116.152 -0.476 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.6 m -77.54 146.32 36.39 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -75.14 -55.24 5.93 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.026 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.76 107.23 7.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.1 t80 -62.3 -45.49 92.99 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.984 -175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -57.7 -34.32 69.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.393 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.97 -28.42 64.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.577 0.751 . . . . 0.0 111.065 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -74.95 -18.49 60.38 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.268 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 -157.35 16.55 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.35 113.92 27.02 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.598 0.199 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 76.6 t80 63.92 95.45 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.106 1.362 . . . . 0.0 113.724 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -132.73 160.44 36.8 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -106.64 149.8 26.85 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.1 m -101.14 132.87 46.41 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 120.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.77 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.345 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 68.22 19.99 8.95 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.643 1.577 . . . . 0.0 111.187 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.37 6.19 74.6 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.7 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.04 144.32 23.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.0 m -83.05 109.78 17.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.92 134.89 25.7 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.79 158.03 31.46 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.673 1.582 . . . . 0.0 110.155 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.5 tpt -87.53 150.58 23.63 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 tp -106.14 90.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 121.548 0.689 . . . . 0.0 110.844 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.192 0 CA-C-N 116.111 -0.495 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . . . . . . 0 N--CA 1.444 -0.753 0 CA-C-O 120.998 0.428 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.443 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 60.7 m -90.66 145.89 24.47 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 172.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' HB2' ' HZ3' ' A' ' 3' ' ' LYS . 9.7 mtmp? -57.28 -56.17 25.35 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.9 80.92 1.43 Allowed 'General case' 0 N--CA 1.414 -2.269 0 CA-C-O 122.816 1.293 . . . . 0.0 111.545 177.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -64.49 -45.69 86.21 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.853 -174.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -65.43 -25.34 67.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.137 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -84.07 -50.98 7.47 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.538 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 54.5 m -71.96 -42.96 65.94 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.626 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.51 159.3 25.77 Favored Glycine 0 C--O 1.254 1.392 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.577 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.94 4.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.942 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 179.22 -32.36 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 125.192 1.397 . . . . 0.0 107.501 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.02 149.32 27.03 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.036 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.49 146.34 24.16 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.1 m -101.36 120.73 40.72 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -132.88 111.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 65.84 22.63 11.42 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.266 1.426 . . . . 0.0 111.04 -176.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 1' ' ' ALA . . . 88.79 -6.77 83.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.807 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.82 135.73 25.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 2' ' ' CYS . 20.1 m -82.02 110.0 16.87 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.38 152.08 77.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.412 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.98 145.64 25.11 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.872 1.714 . . . . 0.0 108.372 170.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.2 ttp -86.72 149.05 25.15 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.051 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.8 tt -130.42 94.7 2.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.607 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.204 0 O-C-N 121.968 -0.457 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.42 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.844 0.354 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.1 m -81.4 123.45 28.57 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -77.9 -55.21 5.5 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.49 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -118.45 141.86 48.14 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.12 -48.76 6.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -50.28 -44.66 53.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.53 1.532 . . . . 0.0 113.638 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.58 -26.15 63.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.124 0.964 . . . . 0.0 110.596 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 59.4 m -92.64 -30.68 15.47 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.005 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.32 -146.48 18.15 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.38 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.49 122.04 46.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 60.42 101.01 0.02 OUTLIER 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.84 1.256 . . . . 0.0 111.135 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.485 HD21 ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -135.36 162.95 31.16 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.356 -175.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.66 141.68 44.96 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.485 ' SG ' HD21 ' A' ' 12' ' ' LEU . 76.0 m -116.66 138.35 51.51 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.64 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.43 106.03 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.184 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 63.34 26.32 14.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.187 1.395 . . . . 0.0 112.317 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 1' ' ' ALA . . . 99.66 -17.77 57.05 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.376 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.38 132.27 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 m -98.92 150.02 22.35 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.029 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.03 120.17 30.44 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.61 165.33 27.81 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.461 2.108 . . . . 0.0 113.277 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -53.16 141.57 22.86 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.439 1.095 . . . . 0.0 110.453 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.6 mt -106.58 97.3 5.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.15 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.495 0 CA-C-N 116.252 -0.431 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.94 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.7 m -73.18 122.07 21.3 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.4 -55.39 4.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -104.63 89.43 3.19 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -79.09 -38.74 35.52 Favored 'General case' 0 C--N 1.261 -3.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.962 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -52.81 -33.91 51.35 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.783 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.28 -31.33 65.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.613 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.2 m -81.35 -41.26 22.28 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.39 161.53 14.57 Favored Glycine 0 N--CA 1.417 -2.575 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.058 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.52 126.28 28.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 80.8 7.57 1.3 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.119 1.368 . . . . 0.0 113.165 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.4 tp -94.31 101.78 13.75 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.7 153.79 25.15 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.268 -171.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 56.6 m -100.13 127.87 46.3 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -124.64 110.45 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 67.87 23.06 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.704 1.602 . . . . 0.0 109.8 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.29 -20.52 42.41 Favored Glycine 0 C--N 1.309 -0.965 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.022 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 48.3 mm -96.19 138.69 20.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.0 m -81.16 108.99 15.28 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.05 125.16 30.69 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.516 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.6 135.1 15.88 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.127 1.884 . . . . 0.0 111.102 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.98 157.6 34.71 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.0 mt -86.64 99.28 7.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 120.935 0.398 . . . . 0.0 110.265 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 116.393 -0.367 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m -77.88 149.99 34.2 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.96 -42.11 9.64 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 40.5 mt-10 -107.75 115.63 30.5 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -53.9 -49.56 68.33 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.869 0.842 . . . . 0.0 111.166 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.474 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 37.7 p90 -63.4 -9.88 14.37 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.945 -1.48 . . . . 0.0 114.349 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.63 -56.7 12.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.552 0.691 . . . . 0.0 110.818 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.48 -25.83 5.93 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.222 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.13 152.64 15.25 Favored Glycine 0 C--O 1.247 0.925 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.72 93.61 8.48 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.606 0.717 . . . . 0.0 110.6 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -172.96 -45.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.45 162.9 17.02 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 71.3 m-85 -98.32 168.76 10.02 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 m -138.61 120.42 15.34 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.348 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 tt -98.28 91.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 CA-C-O 122.786 1.279 . . . . 0.0 108.234 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.19 28.09 17.64 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.514 -2.13 . . . . 0.0 112.056 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.99 -16.01 23.18 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.443 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 50.9 mm -86.74 133.49 29.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -81.76 131.28 35.26 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.06 0.457 . . . . 0.0 110.355 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 13' ' ' PHE . 61.6 t -99.74 123.44 47.68 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.96 134.95 67.23 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.543 2.829 . . . . 0.0 113.979 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.6 tpt -81.1 144.96 31.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.429 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.3 89.03 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.688 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 116.236 -0.438 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 56.8 m -100.17 153.78 18.98 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -56.9 -39.55 74.61 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.506 ' HB3' ' HG2' ' A' ' 7' ' ' GLU . 9.4 tp10 -165.79 146.6 6.84 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 168.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -77.92 -53.28 7.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.577 0.703 . . . . 0.0 111.547 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -68.82 -26.19 65.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 9.4 pt-20 -72.16 -27.68 62.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.401 0.62 . . . . 0.0 110.868 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.2 m -83.57 -39.4 20.42 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.507 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.29 -146.25 18.21 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.3 122.37 46.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 57.29 82.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.906 1.282 . . . . 0.0 114.088 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.65 131.62 53.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.43 118.08 24.74 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 60.2 m -100.83 144.87 29.26 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.831 -171.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.2 mt -139.5 121.3 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 68.59 22.18 7.71 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.397 1.479 . . . . 0.0 109.772 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -15.98 59.89 Favored Glycine 0 C--N 1.305 -1.158 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.705 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.42 131.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 58.0 m -81.36 109.63 16.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.58 110.76 62.66 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.144 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.68 160.63 19.13 Favored 'Trans proline' 0 N--CA 1.432 -2.137 0 C-N-CA 121.766 1.644 . . . . 0.0 110.999 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 55.0 ttp -61.47 155.7 21.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.08 91.3 3.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.098 0 CA-C-N 116.102 -0.499 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 80.3 m -81.78 147.45 29.41 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 123.162 0.288 . . . . 0.0 110.676 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -79.75 -33.49 40.68 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.286 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -73.8 78.37 1.59 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.325 1.06 . . . . 0.0 112.055 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -72.17 -44.1 63.57 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.09 -1.413 . . . . 0.0 108.251 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -60.05 -35.05 74.28 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.59 -49.41 12.23 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.23 -42.24 55.74 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.075 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.09 -170.43 15.03 Favored Glycine 0 C--N 1.299 -1.499 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 95.16 1.47 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 60.47 85.77 0.11 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.38 156.47 23.4 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 22' ' ' MET . 82.8 m-85 -100.12 163.75 12.28 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.6 m -123.33 137.6 54.8 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.162 -1.015 . . . . 0.0 113.507 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.27 105.03 13.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 66.34 22.12 10.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 126.314 1.845 . . . . 0.0 110.534 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.82 -7.55 63.06 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.918 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mm -87.08 125.41 40.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.3 m -81.3 121.6 26.39 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.461 0.476 . . . . 0.0 110.261 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.54 160.09 66.6 Favored Pre-proline 0 C--N 1.305 -1.339 0 C-N-CA 124.033 0.933 . . . . 0.0 108.987 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.32 137.97 49.27 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.483 1.456 . . . . 0.0 109.022 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.541 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . 54.6 ttp -63.4 135.53 57.02 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.981 0.896 . . . . 0.0 112.593 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -94.29 98.91 8.67 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.528 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.569 0 CA-C-N 116.549 -0.296 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.273 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.6 m -72.98 144.82 47.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.786 0.327 . . . . 0.0 110.735 -178.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -77.56 -42.62 34.67 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -89.88 88.25 7.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.254 176.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 26.3 t80 -85.2 -27.81 25.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -61.18 -25.25 66.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.646 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.35 -33.14 69.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.95 0.881 . . . . 0.0 109.484 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.3 m -76.19 -43.42 42.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.527 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.76 -148.1 18.91 Favored Glycine 0 C--N 1.298 -1.53 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.42 105.91 17.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.065 -178.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 97.7 m-85 65.45 86.61 0.13 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.692 1.197 . . . . 0.0 114.094 175.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 11' ' ' PHE . 3.7 mm? -136.39 162.91 31.73 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.215 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -108.25 154.02 22.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.59 139.22 50.75 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.391 0.615 . . . . 0.0 111.699 -178.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 tt -140.19 108.97 3.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.278 175.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 61.38 26.94 16.64 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.105 1.362 . . . . 0.0 112.071 178.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.81 -9.85 64.13 Favored Glycine 0 C--N 1.313 -0.713 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.187 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.12 128.38 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.0 m -87.59 118.06 26.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.99 140.06 30.27 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.591 -179.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.51 116.54 4.58 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 122.38 2.053 . . . . 0.0 110.958 175.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -98.98 156.39 16.94 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 tt -116.03 92.72 2.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.75 0.786 . . . . 0.0 110.501 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 115.87 -0.604 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 96.1 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 120.501 0.191 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -60.1 -52.54 64.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.853 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -93.96 101.98 14.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.35 -42.91 95.99 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.72 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -63.66 -18.91 64.45 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.983 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.48 -36.42 78.92 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.053 0.93 . . . . 0.0 108.501 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -82.45 -43.5 17.18 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.805 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.71 -131.31 9.26 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.02 106.74 16.81 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.1 0.45 . . . . 0.0 110.746 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.406 ' C ' HD22 ' A' ' 12' ' ' LEU . 87.7 t80 53.32 94.46 0.02 OUTLIER 'General case' 0 C--O 1.246 0.89 0 C-N-CA 125.323 1.449 . . . . 0.0 113.899 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.8 mm? -131.8 163.35 28.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -99.49 129.79 45.69 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.6 m -100.34 126.95 46.75 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 122.363 1.077 . . . . 0.0 111.475 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tt -128.21 100.13 5.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.536 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 59.89 34.54 21.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.856 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.58 -10.18 60.89 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.153 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.53 122.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.2 m -87.62 109.98 20.06 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.17 152.77 43.99 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.445 -1.362 0 C-N-CA 121.221 1.281 . . . . 0.0 109.898 175.351 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -96.81 -21.87 17.27 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.836 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.63 95.2 3.55 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.739 0.781 . . . . 0.0 109.115 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.488 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.9 t80 -61.89 -46.42 89.47 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.458 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -65.69 -19.97 66.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.15 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.35 -18.33 60.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 109.703 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.9 m -100.5 4.92 43.98 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.154 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.41 -147.22 17.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.707 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.82 128.66 56.5 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 122.384 0.273 . . . . 0.0 110.395 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 47.0 t80 54.09 99.48 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.051 1.74 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -132.59 156.56 46.67 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 130.48 56.39 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -101.38 137.81 39.22 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.9 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 tp -153.31 122.77 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 65.57 20.91 11.7 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.731 1.213 . . . . 0.0 110.953 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.34 -3.81 82.23 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.957 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.65 132.06 40.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.55 116.31 22.51 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.49 121.24 34.91 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.368 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.446 -1.314 0 C-N-CA 122.229 1.952 . . . . 0.0 110.816 173.874 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HB3' ' OE2' ' A' ' 7' ' ' GLU . 34.9 m . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.09 -48.51 17.6 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.937 -173.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 70.1 mm-40 -122.95 160.2 26.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.79 -45.72 34.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.291 1.043 . . . . 0.0 108.478 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.8 p-90 -68.38 -9.8 50.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.439 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 2' ' ' CYS . 42.2 tt0 -63.95 -36.99 85.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.831 0.824 . . . . 0.0 109.003 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 72.5 m -92.82 -43.83 8.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.995 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.26 177.62 14.96 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.869 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.62 122.42 19.06 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 68.42 16.0 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.491 1.116 . . . . 0.0 112.737 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -103.53 102.67 12.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.95 168.9 11.08 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.44 128.84 47.47 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.14 111.99 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 65.62 21.57 11.68 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 126.649 1.979 . . . . 0.0 111.003 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.38 -2.47 74.37 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.961 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.93 137.49 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 38.0 m -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -140.41 153.05 68.15 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 C-N-CA 121.629 1.553 . . . . 0.0 109.425 175.266 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.2 m . . . . . 0 N--CA 1.439 -0.992 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.49 -55.66 2.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -135.68 104.69 5.87 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.39 -48.09 83.25 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.66 0.743 . . . . 0.0 110.336 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -61.89 -27.07 68.55 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.165 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -71.58 -30.74 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.1 0.953 . . . . 0.0 109.693 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.16 -42.57 10.98 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.718 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.51 -177.37 16.51 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.93 140.91 29.94 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 72.89 16.82 4.41 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.07 145.93 28.99 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -111.93 141.76 45.17 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.03 127.79 47.38 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-O 122.085 0.945 . . . . 0.0 110.807 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -135.83 114.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 66.65 24.48 10.07 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 125.401 1.481 . . . . 0.0 110.85 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.46 0.46 89.37 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.109 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.6 mt -105.42 139.38 26.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.12 114.46 25.73 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.979 0.419 . . . . 0.0 110.327 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.09 133.68 23.4 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--O 1.241 0.625 0 C-N-CA 122.009 1.806 . . . . 0.0 109.816 174.807 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.245 0.834 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -105.03 -56.17 2.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.947 0.403 . . . . 0.0 111.2 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -121.41 130.27 53.5 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.262 0.553 . . . . 0.0 110.692 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -63.61 -45.31 90.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.777 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -68.06 -16.76 64.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.175 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.08 -32.82 71.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.67 0.748 . . . . 0.0 109.123 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.3 m -85.03 -37.59 20.18 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.906 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.85 -60.3 0.57 Allowed Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.6 174.87 5.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -74.13 99.13 3.29 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.487 1.137 . . . . 0.0 111.2 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.4 tp -129.37 156.19 44.45 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.394 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 93.5 m-85 -82.7 141.92 32.06 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.687 0.28 . . . . 0.0 110.468 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -106.69 130.87 54.35 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.409 0.623 . . . . 0.0 109.851 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 112.08 20.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 63.44 24.04 13.96 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.562 1.145 . . . . 0.0 112.77 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.59 75.25 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.426 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mt -106.4 127.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 11.3 m -83.17 112.3 19.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.63 138.01 31.67 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--O 1.253 1.243 0 C-N-CA 122.257 1.971 . . . . 0.0 110.268 174.433 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -72.3 -56.16 5.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.46 124.24 19.86 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -56.08 -52.46 64.22 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 123.664 0.786 . . . . 0.0 110.841 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -63.55 -17.07 62.43 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 124.648 1.179 . . . . 0.0 113.448 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.68 -22.46 56.67 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.804 0.812 . . . . 0.0 109.739 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.1 m -120.23 -42.68 2.56 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.574 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.65 -161.66 12.63 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.62 155.07 18.08 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 122.521 0.328 . . . . 0.0 110.249 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 68.83 14.01 8.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.37 140.74 32.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.85 107.54 18.73 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 67.7 m -101.35 141.76 33.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.705 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 tt -144.73 114.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 64.83 22.57 12.54 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.973 1.309 . . . . 0.0 111.899 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.49 -18.0 49.09 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.976 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 46.5 mm -85.95 130.51 36.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 m -96.49 111.15 23.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.63 115.23 60.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.108 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 N--CA 1.443 -1.48 0 N-CA-C 107.718 -1.685 . . . . 0.0 107.718 170.554 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 46.2 m . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -97.89 -55.42 2.8 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.46 82.72 1.64 Allowed 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 122.849 1.309 . . . . 0.0 111.653 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.13 -40.89 82.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.842 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -63.8 -22.85 67.11 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.565 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -91.11 -17.97 25.29 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.943 0.877 . . . . 0.0 109.594 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.83 -38.7 11.61 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.068 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.7 171.95 14.18 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.3 36.02 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.457 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 72.86 28.14 2.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.035 1.334 . . . . 0.0 112.158 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 3.9 mm? -91.33 119.35 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.425 173.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -95.17 156.38 16.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.38 152.92 31.97 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.487 0.661 . . . . 0.0 112.782 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.1 mt -143.0 119.13 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 71.33 11.1 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.274 1.43 . . . . 0.0 111.349 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.23 70.57 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.9 mt -97.0 126.74 49.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 20.4 m -80.89 116.36 20.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.96 131.09 22.39 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-O 121.213 0.53 . . . . 0.0 111.768 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.439 -1.691 0 C-N-CA 122.168 1.912 . . . . 0.0 110.685 172.844 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.239 0.545 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -106.07 -55.69 2.29 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.944 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -134.33 112.54 11.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.692 0.797 . . . . 0.0 109.524 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -63.3 -42.99 99.09 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.47 1.108 . . . . 0.0 111.366 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -59.92 -26.66 66.12 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.385 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.23 -19.64 42.75 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.705 0.802 . . . . 0.0 111.513 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 82.7 m -100.68 -39.35 7.9 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.786 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.41 -140.37 11.81 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.401 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.57 118.73 35.89 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.635 0.217 . . . . 0.0 111.231 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 47.72 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.503 1.521 . . . . 0.0 112.724 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' A' ' 8' ' ' CYS . 1.4 mm? -118.5 163.61 16.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.645 -174.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 20' ' ' VAL . 54.1 t80 -102.57 115.42 30.55 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 173.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 m -101.63 132.25 47.41 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.44 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.5 tt -131.4 105.82 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 CA-C-O 121.895 0.855 . . . . 0.0 109.746 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 65.01 21.02 12.24 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.859 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.13 -8.07 41.45 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.912 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.48 119.4 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -92.89 118.85 31.59 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 13' ' ' PHE . 27.5 m -104.4 153.81 38.81 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 N--CA 1.459 -0.502 0 C-N-CA 121.992 1.795 . . . . 0.0 110.289 178.89 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -96.99 -56.35 2.58 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.948 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.17 97.77 8.55 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.88 -52.24 60.88 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.941 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -57.34 -25.16 58.96 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 126.425 1.89 . . . . 0.0 113.234 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -70.6 -30.56 67.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.297 1.046 . . . . 0.0 109.444 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 64.3 m -97.98 -42.34 7.56 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.607 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.6 -173.32 20.15 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.81 33.7 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.712 0.292 . . . . 0.0 110.916 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 69.39 23.59 6.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.219 1.408 . . . . 0.0 112.016 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.33 118.3 23.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.564 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.5 m -100.8 140.62 34.82 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 tt -126.76 109.78 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 70.88 19.4 5.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.442 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 -20.91 45.65 Favored Glycine 0 C--O 1.236 0.226 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.11 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.19 127.81 41.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 m -81.99 109.64 16.51 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -101.32 126.05 35.82 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo . . . . . 0 C--N 1.36 1.162 0 C-N-CA 123.385 2.723 . . . . 0.0 111.164 178.134 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -80.05 -55.96 4.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.262 0.553 . . . . 0.0 109.556 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -136.2 106.09 6.25 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.167 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.29 -46.81 85.02 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.17 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -60.19 -29.65 68.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.823 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.34 -44.4 75.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.63 0.729 . . . . 0.0 109.922 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.5 m -77.48 -39.57 46.0 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.804 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.36 165.34 12.06 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.41 142.86 35.57 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 69.12 25.25 5.84 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.545 1.138 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.33 149.61 22.25 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.4 143.18 45.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.3 m -106.54 133.54 51.07 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.393 0.616 . . . . 0.0 110.624 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 tt -145.31 114.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 63.28 23.47 13.83 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.753 1.221 . . . . 0.0 112.106 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.99 69.92 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -100.55 124.09 53.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -89.6 109.96 20.87 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.86 129.28 6.77 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 N--CA 1.444 -1.41 0 C-N-CA 122.11 1.873 . . . . 0.0 111.408 -179.017 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.5 m . . . . . 0 C--O 1.237 0.447 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 34.9 mtmm -79.95 -55.5 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 45.0 mm-40 -117.57 156.27 28.38 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -70.44 -59.09 3.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.772 0.796 . . . . 0.0 111.394 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -60.94 -15.19 28.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.602 1.161 . . . . 0.0 112.646 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.7 tt0 -55.68 -41.62 73.97 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 124.841 1.257 . . . . 0.0 110.334 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.0 m -106.55 -30.46 9.03 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.536 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.95 -165.47 12.04 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.85 132.53 33.8 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 120.644 0.259 . . . . 0.0 111.096 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 70.04 16.42 7.55 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.142 1.377 . . . . 0.0 114.549 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.94 142.57 27.89 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -95.34 115.65 27.71 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.4 m -100.42 126.66 46.84 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.3 -175.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.3 mt -113.19 104.84 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.569 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 65.44 25.13 11.94 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 125.486 1.514 . . . . 0.0 111.854 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.2 -8.75 57.46 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.214 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 81.3 mt -92.01 134.17 31.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.39 114.9 22.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.228 0.537 . . . . 0.0 109.934 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.96 144.84 44.1 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 C--O 1.247 0.94 0 C-N-CA 122.108 1.872 . . . . 0.0 111.335 175.008 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -78.14 -55.82 4.96 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.408 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.35 140.12 39.33 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -54.61 -52.73 61.3 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.322 1.449 . . . . 0.0 111.258 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -63.54 -23.77 67.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.604 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.93 -26.89 62.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.155 0.979 . . . . 0.0 109.831 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 58.5 m -102.34 5.04 39.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.399 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.24 -81.56 1.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.71 175.83 5.27 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.98 118.3 7.62 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 33.0 tp -136.66 162.36 33.38 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -82.66 137.42 34.48 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 57.3 m -114.07 142.36 46.29 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.72 110.51 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 62.61 25.79 15.32 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.63 -15.05 56.18 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.083 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 70.9 mt -89.26 117.42 32.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.75 109.23 15.96 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.85 125.31 38.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo . . . . . 0 C--N 1.353 0.815 0 C-N-CA 123.659 2.906 . . . . 0.0 111.683 177.104 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 84.9 m . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.33 -54.14 7.58 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -82.14 95.92 7.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -74.63 -44.14 51.98 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.925 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -59.93 -25.63 65.32 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.099 -1.41 . . . . 0.0 112.268 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.78 -18.5 64.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.788 0.804 . . . . 0.0 110.312 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 59.6 m -98.02 -1.59 42.25 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.79 -149.12 29.57 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.216 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.58 111.33 22.89 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.803 0.302 . . . . 0.0 111.518 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 50.01 80.89 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.14 1.376 . . . . 0.0 113.772 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 17.0 tp -131.07 136.88 48.82 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 86.9 m-85 -82.75 154.75 24.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.487 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.4 m -100.97 132.12 46.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.406 ' HB ' HG12 ' A' ' 20' ' ' VAL . 45.7 mm -137.69 117.53 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 65.93 19.52 11.26 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 125.404 1.482 . . . . 0.0 112.074 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.7 -8.9 60.14 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.491 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.7 mt -115.54 145.44 21.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 67.4 m -83.89 129.49 34.93 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.121 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.406 HG12 ' HB ' ' A' ' 15' ' ' ILE . 14.5 p -142.03 141.04 20.55 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--O 1.24 0.622 0 C-N-CA 122.25 1.967 . . . . 0.0 112.657 178.888 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -75.14 -55.24 5.93 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.026 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.76 107.23 7.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.1 t80 -62.3 -45.49 92.99 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.984 -175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -57.7 -34.32 69.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.393 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.97 -28.42 64.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.577 0.751 . . . . 0.0 111.065 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -74.95 -18.49 60.38 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.268 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 -157.35 16.55 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.35 113.92 27.02 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.598 0.199 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 76.6 t80 63.92 95.45 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.106 1.362 . . . . 0.0 113.724 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.7 mm? -132.73 160.44 36.8 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -106.64 149.8 26.85 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.1 m -101.14 132.87 46.41 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 120.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.77 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.345 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 68.22 19.99 8.95 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.643 1.577 . . . . 0.0 111.187 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.37 6.19 74.6 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.7 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.04 144.32 23.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.0 m -83.05 109.78 17.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.92 134.89 25.7 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo . . . . . 0 N--CA 1.454 -0.83 0 C-N-CA 121.673 1.582 . . . . 0.0 110.155 173.771 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.446 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 60.7 m . . . . . 0 C--O 1.243 0.72 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.28 -56.17 25.35 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.402 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -107.9 80.92 1.43 Allowed 'General case' 0 N--CA 1.414 -2.269 0 CA-C-O 122.816 1.293 . . . . 0.0 111.545 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -64.49 -45.69 86.21 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.853 -174.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -65.43 -25.34 67.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.137 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -84.07 -50.98 7.47 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.538 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.402 ' SG ' ' HG2' ' A' ' 4' ' ' GLU . 54.5 m -71.96 -42.96 65.94 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.626 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.51 159.3 25.77 Favored Glycine 0 C--O 1.254 1.392 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.577 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.94 4.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.942 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 179.22 -32.36 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 125.192 1.397 . . . . 0.0 107.501 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.02 149.32 27.03 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.036 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.49 146.34 24.16 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.1 m -101.36 120.73 40.72 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -132.88 111.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 65.84 22.63 11.42 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.266 1.426 . . . . 0.0 111.04 -176.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.79 -6.77 83.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.807 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.82 135.73 25.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 2' ' ' CYS . 20.1 m -82.02 110.0 16.87 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.38 152.08 77.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.412 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo . . . . . 0 N--CA 1.45 -1.08 0 C-N-CA 121.872 1.714 . . . . 0.0 108.372 170.835 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -77.9 -55.21 5.5 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.49 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -118.45 141.86 48.14 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.12 -48.76 6.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -50.28 -44.66 53.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.53 1.532 . . . . 0.0 113.638 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.58 -26.15 63.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.124 0.964 . . . . 0.0 110.596 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.485 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 59.4 m -92.64 -30.68 15.47 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.005 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.32 -146.48 18.15 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.38 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.49 122.04 46.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 60.42 101.01 0.02 OUTLIER 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.84 1.256 . . . . 0.0 111.135 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -135.36 162.95 31.16 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.356 -175.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.66 141.68 44.96 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 12' ' ' LEU . 76.0 m -116.66 138.35 51.51 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.64 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.43 106.03 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.184 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 63.34 26.32 14.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.187 1.395 . . . . 0.0 112.317 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.66 -17.77 57.05 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.376 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.38 132.27 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 m -98.92 150.02 22.35 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.029 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.03 120.17 30.44 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.461 2.108 . . . . 0.0 113.277 -176.57 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.4 -55.39 4.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -104.63 89.43 3.19 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -79.09 -38.74 35.52 Favored 'General case' 0 C--N 1.261 -3.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.962 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -52.81 -33.91 51.35 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.783 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.28 -31.33 65.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.613 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.2 m -81.35 -41.26 22.28 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.39 161.53 14.57 Favored Glycine 0 N--CA 1.417 -2.575 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.058 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.52 126.28 28.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 80.8 7.57 1.3 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.119 1.368 . . . . 0.0 113.165 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 12' ' ' LEU . 20.4 tp -94.31 101.78 13.75 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.7 153.79 25.15 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.268 -171.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 56.6 m -100.13 127.87 46.3 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -124.64 110.45 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 67.87 23.06 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.704 1.602 . . . . 0.0 109.8 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.29 -20.52 42.41 Favored Glycine 0 C--N 1.309 -0.965 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.022 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 48.3 mm -96.19 138.69 20.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.0 m -81.16 108.99 15.28 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.05 125.16 30.69 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.516 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.448 -1.156 0 C-N-CA 122.127 1.884 . . . . 0.0 111.102 175.868 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.505 -0.778 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.96 -42.11 9.64 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 40.5 mt-10 -107.75 115.63 30.5 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -53.9 -49.56 68.33 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.869 0.842 . . . . 0.0 111.166 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.477 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 37.7 p90 -63.4 -9.88 14.37 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.945 -1.48 . . . . 0.0 114.349 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.63 -56.7 12.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.552 0.691 . . . . 0.0 110.818 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.48 -25.83 5.93 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.222 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.13 152.64 15.25 Favored Glycine 0 C--O 1.247 0.925 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -174.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.72 93.61 8.48 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.606 0.717 . . . . 0.0 110.6 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -172.96 -45.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.45 162.9 17.02 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 71.3 m-85 -98.32 168.76 10.02 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 m -138.61 120.42 15.34 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.348 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.477 HG23 ' HB ' ' A' ' 18' ' ' ILE . 10.2 tt -98.28 91.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 CA-C-O 122.786 1.279 . . . . 0.0 108.234 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.19 28.09 17.64 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.514 -2.13 . . . . 0.0 112.056 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.99 -16.01 23.18 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.443 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 15' ' ' ILE . 50.9 mm -86.74 133.49 29.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -81.76 131.28 35.26 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.06 0.457 . . . . 0.0 110.355 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 13' ' ' PHE . 61.6 t -99.74 123.44 47.68 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 C--O 1.245 0.867 0 C-N-CA 123.543 2.829 . . . . 0.0 113.979 -176.626 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 C--O 1.246 0.88 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -56.9 -39.55 74.61 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 7' ' ' GLU . 9.4 tp10 -165.79 146.6 6.84 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 168.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -77.92 -53.28 7.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.577 0.703 . . . . 0.0 111.547 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -68.82 -26.19 65.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 9.4 pt-20 -72.16 -27.68 62.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.401 0.62 . . . . 0.0 110.868 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.2 m -83.57 -39.4 20.42 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.507 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.29 -146.25 18.21 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.3 122.37 46.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 57.29 82.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.906 1.282 . . . . 0.0 114.088 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.65 131.62 53.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.43 118.08 24.74 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 60.2 m -100.83 144.87 29.26 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.831 -171.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.2 mt -139.5 121.3 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 68.59 22.18 7.71 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.397 1.479 . . . . 0.0 109.772 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -15.98 59.89 Favored Glycine 0 C--N 1.305 -1.158 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.705 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.42 131.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 58.0 m -81.36 109.63 16.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.58 110.76 62.66 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.144 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 N--CA 1.432 -2.137 0 C-N-CA 121.766 1.644 . . . . 0.0 110.999 176.849 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 80.3 m . . . . . 0 C--O 1.241 0.626 0 CA-C-O 120.491 0.186 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -79.75 -33.49 40.68 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.286 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -73.8 78.37 1.59 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.325 1.06 . . . . 0.0 112.055 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -72.17 -44.1 63.57 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.09 -1.413 . . . . 0.0 108.251 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -60.05 -35.05 74.28 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.59 -49.41 12.23 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.23 -42.24 55.74 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.075 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.09 -170.43 15.03 Favored Glycine 0 C--N 1.299 -1.499 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 95.16 1.47 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 60.47 85.77 0.11 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.38 156.47 23.4 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 82.8 m-85 -100.12 163.75 12.28 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.6 m -123.33 137.6 54.8 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.162 -1.015 . . . . 0.0 113.507 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.27 105.03 13.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 66.34 22.12 10.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 126.314 1.845 . . . . 0.0 110.534 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.82 -7.55 63.06 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.918 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mm -87.08 125.41 40.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 79.3 m -81.3 121.6 26.39 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.461 0.476 . . . . 0.0 110.261 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.54 160.09 66.6 Favored Pre-proline 0 C--N 1.305 -1.339 0 C-N-CA 124.033 0.933 . . . . 0.0 108.987 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--O 1.243 0.77 0 C-N-CA 121.483 1.456 . . . . 0.0 109.022 170.583 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 CA--C 1.517 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -77.56 -42.62 34.67 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -89.88 88.25 7.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.254 176.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 26.3 t80 -85.2 -27.81 25.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -61.18 -25.25 66.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.646 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.35 -33.14 69.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.95 0.881 . . . . 0.0 109.484 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 59.3 m -76.19 -43.42 42.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.527 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.76 -148.1 18.91 Favored Glycine 0 C--N 1.298 -1.53 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.42 105.91 17.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.065 -178.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 97.7 m-85 65.45 86.61 0.13 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.692 1.197 . . . . 0.0 114.094 175.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 3.7 mm? -136.39 162.91 31.73 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.215 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -108.25 154.02 22.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.59 139.22 50.75 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.391 0.615 . . . . 0.0 111.699 -178.248 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 tt -140.19 108.97 3.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.278 175.045 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 61.38 26.94 16.64 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.105 1.362 . . . . 0.0 112.071 178.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.81 -9.85 64.13 Favored Glycine 0 C--N 1.313 -0.713 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.187 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.12 128.38 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.0 m -87.59 118.06 26.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.0 m -120.99 140.06 30.27 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.591 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 20' ' ' VAL . 14.2 Cg_exo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 122.38 2.053 . . . . 0.0 110.958 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.487 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 96.1 m -58.58 157.32 9.3 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.345 0.658 . . . . 0.0 110.604 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -60.1 -52.54 64.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.853 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -93.96 101.98 14.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.35 -42.91 95.99 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.72 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -63.66 -18.91 64.45 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.983 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.48 -36.42 78.92 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.053 0.93 . . . . 0.0 108.501 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -82.45 -43.5 17.18 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.805 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.71 -131.31 9.26 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.02 106.74 16.81 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.1 0.45 . . . . 0.0 110.746 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.406 ' C ' HD22 ' A' ' 12' ' ' LEU . 87.7 t80 53.32 94.46 0.02 OUTLIER 'General case' 0 C--O 1.246 0.89 0 C-N-CA 125.323 1.449 . . . . 0.0 113.899 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.8 mm? -131.8 163.35 28.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -99.49 129.79 45.69 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.6 m -100.34 126.95 46.75 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 122.363 1.077 . . . . 0.0 111.475 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tt -128.21 100.13 5.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.536 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 59.89 34.54 21.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.856 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.58 -10.18 60.89 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.153 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.53 122.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.2 m -87.62 109.98 20.06 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.17 152.77 43.99 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.37 130.96 18.15 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 121.221 1.281 . . . . 0.0 109.898 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.9 ttp -78.25 149.56 33.58 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.005 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mp -97.98 -80.43 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.898 0 O-C-N 122.22 -0.3 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 69.0 m -78.47 130.76 36.42 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -96.81 -21.87 17.27 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.836 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.63 95.2 3.55 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.739 0.781 . . . . 0.0 109.115 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.488 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.9 t80 -61.89 -46.42 89.47 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.458 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -65.69 -19.97 66.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.15 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.35 -18.33 60.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 109.703 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.9 m -100.5 4.92 43.98 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.154 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.41 -147.22 17.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.707 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.82 128.66 56.5 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 122.384 0.273 . . . . 0.0 110.395 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 47.0 t80 54.09 99.48 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.051 1.74 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -132.59 156.56 46.67 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 130.48 56.39 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -101.38 137.81 39.22 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.9 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 tp -153.31 122.77 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 65.57 20.91 11.7 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.731 1.213 . . . . 0.0 110.953 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.34 -3.81 82.23 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.957 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.65 132.06 40.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.55 116.31 22.51 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.49 121.24 34.91 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.368 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -84.84 137.5 6.53 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.229 1.952 . . . . 0.0 110.816 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.07 155.23 27.64 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.0 mt -83.0 -84.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.937 0 O-C-N 122.08 -0.387 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.645 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HB3' ' OE2' ' A' ' 7' ' ' GLU . 34.9 m -75.04 170.14 16.6 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.09 -48.51 17.6 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.937 -173.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 70.1 mm-40 -122.95 160.2 26.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.79 -45.72 34.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.291 1.043 . . . . 0.0 108.478 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.8 p-90 -68.38 -9.8 50.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.439 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 2' ' ' CYS . 42.2 tt0 -63.95 -36.99 85.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.831 0.824 . . . . 0.0 109.003 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 72.5 m -92.82 -43.83 8.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.995 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.26 177.62 14.96 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.869 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.62 122.42 19.06 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 68.42 16.0 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.491 1.116 . . . . 0.0 112.737 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -103.53 102.67 12.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.95 168.9 11.08 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.44 128.84 47.47 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.14 111.99 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 65.62 21.57 11.68 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 126.649 1.979 . . . . 0.0 111.003 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.38 -2.47 74.37 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.961 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.93 137.49 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 38.0 m -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -140.41 153.05 68.15 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.95 130.98 16.23 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.629 1.553 . . . . 0.0 109.425 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.6 ttt -77.81 140.97 39.46 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 tp -124.65 -62.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.93 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.164 0 O-C-N 121.919 -0.488 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.901 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.2 m -99.78 147.59 25.31 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.49 -55.66 2.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -135.68 104.69 5.87 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.39 -48.09 83.25 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.66 0.743 . . . . 0.0 110.336 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -61.89 -27.07 68.55 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.165 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -71.58 -30.74 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.1 0.953 . . . . 0.0 109.693 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.16 -42.57 10.98 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.718 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.51 -177.37 16.51 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.93 140.91 29.94 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 72.89 16.82 4.41 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.07 145.93 28.99 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -111.93 141.76 45.17 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.03 127.79 47.38 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-O 122.085 0.945 . . . . 0.0 110.807 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -135.83 114.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 66.65 24.48 10.07 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 125.401 1.481 . . . . 0.0 110.85 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.46 0.46 89.37 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.109 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.6 mt -105.42 139.38 26.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.12 114.46 25.73 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.979 0.419 . . . . 0.0 110.327 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.09 133.68 23.4 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.06 129.83 19.08 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 122.009 1.806 . . . . 0.0 109.816 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.6 tpt -102.73 151.51 22.31 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-O 121.032 0.444 . . . . 0.0 110.727 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tt -95.65 93.99 4.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.125 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.576 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.4 m -66.36 142.54 57.59 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 123.233 0.333 . . . . 0.0 110.539 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -105.03 -56.17 2.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.947 0.403 . . . . 0.0 111.2 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -121.41 130.27 53.5 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.262 0.553 . . . . 0.0 110.692 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -63.61 -45.31 90.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.777 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -68.06 -16.76 64.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.175 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.08 -32.82 71.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.67 0.748 . . . . 0.0 109.123 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.3 m -85.03 -37.59 20.18 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.906 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.85 -60.3 0.57 Allowed Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.6 174.87 5.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -74.13 99.13 3.29 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.487 1.137 . . . . 0.0 111.2 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.4 tp -129.37 156.19 44.45 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.394 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 93.5 m-85 -82.7 141.92 32.06 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.687 0.28 . . . . 0.0 110.468 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -106.69 130.87 54.35 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.409 0.623 . . . . 0.0 109.851 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 112.08 20.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 63.44 24.04 13.96 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.562 1.145 . . . . 0.0 112.77 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.59 75.25 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.426 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mt -106.4 127.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 11.3 m -83.17 112.3 19.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.63 138.01 31.67 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.73 122.39 11.72 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 122.257 1.971 . . . . 0.0 110.268 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.6 ttt -63.11 143.83 57.44 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.487 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -87.03 -73.94 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.143 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.153 0 O-C-N 122.37 -0.207 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.8 m -100.06 166.68 10.91 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -72.3 -56.16 5.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.46 124.24 19.86 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -56.08 -52.46 64.22 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 123.664 0.786 . . . . 0.0 110.841 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -63.55 -17.07 62.43 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 124.648 1.179 . . . . 0.0 113.448 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.68 -22.46 56.67 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.804 0.812 . . . . 0.0 109.739 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.1 m -120.23 -42.68 2.56 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.574 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.65 -161.66 12.63 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.62 155.07 18.08 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 122.521 0.328 . . . . 0.0 110.249 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 68.83 14.01 8.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.37 140.74 32.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.85 107.54 18.73 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 67.7 m -101.35 141.76 33.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.705 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 tt -144.73 114.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 64.83 22.57 12.54 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.973 1.309 . . . . 0.0 111.899 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.49 -18.0 49.09 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.976 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 46.5 mm -85.95 130.51 36.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 m -96.49 111.15 23.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.63 115.23 60.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.108 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.32 112.26 2.95 Favored 'Trans proline' 0 N--CA 1.443 -1.48 0 N-CA-C 107.718 -1.685 . . . . 0.0 107.718 170.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 54.7 ttp -75.36 138.81 42.01 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 121.236 0.541 . . . . 0.0 110.041 -175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 tp -133.14 105.22 7.77 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.278 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.155 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.455 0 CA-C-N 116.119 -0.491 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.613 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 46.2 m -80.51 129.72 34.69 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -97.89 -55.42 2.8 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.46 82.72 1.64 Allowed 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 122.849 1.309 . . . . 0.0 111.653 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.13 -40.89 82.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.842 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -63.8 -22.85 67.11 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.565 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -91.11 -17.97 25.29 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.943 0.877 . . . . 0.0 109.594 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.83 -38.7 11.61 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.068 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.7 171.95 14.18 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.3 36.02 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.457 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 72.86 28.14 2.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.035 1.334 . . . . 0.0 112.158 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 3.9 mm? -91.33 119.35 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.425 173.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -95.17 156.38 16.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.38 152.92 31.97 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.487 0.661 . . . . 0.0 112.782 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.1 mt -143.0 119.13 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 71.33 11.1 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.274 1.43 . . . . 0.0 111.349 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.23 70.57 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.9 mt -97.0 126.74 49.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 20.4 m -80.89 116.36 20.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.96 131.09 22.39 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-O 121.213 0.53 . . . . 0.0 111.768 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.59 144.44 11.29 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 122.168 1.912 . . . . 0.0 110.685 172.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.4 ttt -83.79 152.52 24.59 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.379 0.609 . . . . 0.0 110.665 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 tp -82.31 96.37 3.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.867 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.242 0 CA-C-N 115.975 -0.557 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 120.529 0.204 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.8 m -97.84 143.99 27.88 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -106.07 -55.69 2.29 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.944 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -134.33 112.54 11.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.692 0.797 . . . . 0.0 109.524 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -63.3 -42.99 99.09 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.47 1.108 . . . . 0.0 111.366 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -59.92 -26.66 66.12 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.385 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.23 -19.64 42.75 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.705 0.802 . . . . 0.0 111.513 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 82.7 m -100.68 -39.35 7.9 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.786 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.41 -140.37 11.81 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.401 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.57 118.73 35.89 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.635 0.217 . . . . 0.0 111.231 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 47.72 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.503 1.521 . . . . 0.0 112.724 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' A' ' 8' ' ' CYS . 1.4 mm? -118.5 163.61 16.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.645 -174.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 20' ' ' VAL . 54.1 t80 -102.57 115.42 30.55 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 173.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 m -101.63 132.25 47.41 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.44 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.5 tt -131.4 105.82 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 CA-C-O 121.895 0.855 . . . . 0.0 109.746 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 65.01 21.02 12.24 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.859 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.13 -8.07 41.45 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.912 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.48 119.4 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -92.89 118.85 31.59 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 13' ' ' PHE . 27.5 m -104.4 153.81 38.81 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.2 121.97 10.44 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 121.992 1.795 . . . . 0.0 110.289 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.1 tpt -69.51 137.63 52.67 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.607 0.718 . . . . 0.0 110.326 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -104.37 97.96 6.24 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.284 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.25 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.514 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.3 m -75.49 129.5 37.37 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -96.99 -56.35 2.58 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.948 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.17 97.77 8.55 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.88 -52.24 60.88 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.941 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -57.34 -25.16 58.96 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 126.425 1.89 . . . . 0.0 113.234 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -70.6 -30.56 67.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.297 1.046 . . . . 0.0 109.444 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 64.3 m -97.98 -42.34 7.56 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.607 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.6 -173.32 20.15 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.81 33.7 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.712 0.292 . . . . 0.0 110.916 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 69.39 23.59 6.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.219 1.408 . . . . 0.0 112.016 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.33 118.3 23.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.564 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.5 m -100.8 140.62 34.82 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 tt -126.76 109.78 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 70.88 19.4 5.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.442 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 -20.91 45.65 Favored Glycine 0 C--O 1.236 0.226 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.11 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.19 127.81 41.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 m -81.99 109.64 16.51 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -101.32 126.05 35.82 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.21 130.78 33.45 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.385 2.723 . . . . 0.0 111.164 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 33.0 tpp -128.39 156.79 42.58 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.1 tt -118.77 -66.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 123.484 0.49 . . . . 0.0 111.892 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.996 0 O-C-N 121.714 -0.616 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.802 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 60.3 m -100.46 137.37 38.97 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -80.05 -55.96 4.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.262 0.553 . . . . 0.0 109.556 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -136.2 106.09 6.25 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.167 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.29 -46.81 85.02 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.17 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -60.19 -29.65 68.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.823 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.34 -44.4 75.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.63 0.729 . . . . 0.0 109.922 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.5 m -77.48 -39.57 46.0 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.804 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.36 165.34 12.06 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.41 142.86 35.57 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 69.12 25.25 5.84 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.545 1.138 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.33 149.61 22.25 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.4 143.18 45.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.3 m -106.54 133.54 51.07 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.393 0.616 . . . . 0.0 110.624 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 tt -145.31 114.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 63.28 23.47 13.83 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.753 1.221 . . . . 0.0 112.106 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.99 69.92 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -100.55 124.09 53.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -89.6 109.96 20.87 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.86 129.28 6.77 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.52 168.76 14.32 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.11 1.873 . . . . 0.0 111.408 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.8 ttp -92.44 152.33 19.75 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 mp -96.04 -78.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.107 0 O-C-N 122.199 -0.313 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . 0 C--O 1.242 0.694 0 CA-C-O 121.336 0.588 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.5 m -88.0 157.26 18.96 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 34.9 mtmm -79.95 -55.5 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 45.0 mm-40 -117.57 156.27 28.38 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -70.44 -59.09 3.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.772 0.796 . . . . 0.0 111.394 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -60.94 -15.19 28.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.602 1.161 . . . . 0.0 112.646 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.7 tt0 -55.68 -41.62 73.97 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 124.841 1.257 . . . . 0.0 110.334 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.0 m -106.55 -30.46 9.03 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.536 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.95 -165.47 12.04 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.85 132.53 33.8 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 120.644 0.259 . . . . 0.0 111.096 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 70.04 16.42 7.55 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.142 1.377 . . . . 0.0 114.549 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.94 142.57 27.89 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -95.34 115.65 27.71 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.4 m -100.42 126.66 46.84 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.3 -175.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.3 mt -113.19 104.84 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.569 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 65.44 25.13 11.94 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 125.486 1.514 . . . . 0.0 111.854 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.2 -8.75 57.46 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.214 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 81.3 mt -92.01 134.17 31.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.39 114.9 22.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.228 0.537 . . . . 0.0 109.934 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.96 144.84 44.1 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.91 134.27 63.09 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.108 1.872 . . . . 0.0 111.335 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 53.0 ttm -78.35 145.3 35.32 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.142 0.496 . . . . 0.0 110.286 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -113.93 88.46 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.756 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.563 0 CA-C-N 116.129 -0.487 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.535 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.2 m -94.37 144.01 25.91 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -78.14 -55.82 4.96 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.408 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.35 140.12 39.33 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -54.61 -52.73 61.3 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.322 1.449 . . . . 0.0 111.258 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -63.54 -23.77 67.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.604 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.93 -26.89 62.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.155 0.979 . . . . 0.0 109.831 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 58.5 m -102.34 5.04 39.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.399 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.24 -81.56 1.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.71 175.83 5.27 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.98 118.3 7.62 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 33.0 tp -136.66 162.36 33.38 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -82.66 137.42 34.48 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 57.3 m -114.07 142.36 46.29 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.72 110.51 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 62.61 25.79 15.32 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.63 -15.05 56.18 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.083 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 70.9 mt -89.26 117.42 32.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.75 109.23 15.96 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.85 125.31 38.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.62 135.55 56.14 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.659 2.906 . . . . 0.0 111.683 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 53.0 ttp -69.35 144.34 53.48 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.285 0.564 . . . . 0.0 109.719 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.4 mm -98.76 97.73 6.34 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.146 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 CA-C-N 116.463 -0.335 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 120.53 0.205 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 84.9 m -70.96 131.78 44.22 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.33 -54.14 7.58 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -82.14 95.92 7.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -74.63 -44.14 51.98 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.925 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -59.93 -25.63 65.32 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.099 -1.41 . . . . 0.0 112.268 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.78 -18.5 64.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.788 0.804 . . . . 0.0 110.312 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 59.6 m -98.02 -1.59 42.25 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.79 -149.12 29.57 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.216 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.58 111.33 22.89 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.803 0.302 . . . . 0.0 111.518 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 50.01 80.89 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.14 1.376 . . . . 0.0 113.772 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 17.0 tp -131.07 136.88 48.82 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 86.9 m-85 -82.75 154.75 24.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.487 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.4 m -100.97 132.12 46.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.406 ' HB ' HG12 ' A' ' 20' ' ' VAL . 45.7 mm -137.69 117.53 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 65.93 19.52 11.26 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 125.404 1.482 . . . . 0.0 112.074 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.7 -8.9 60.14 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.491 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.7 mt -115.54 145.44 21.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 67.4 m -83.89 129.49 34.93 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.121 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.406 HG12 ' HB ' ' A' ' 15' ' ' ILE . 14.5 p -142.03 141.04 20.55 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.99 143.62 66.7 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.25 1.967 . . . . 0.0 112.657 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.67 139.91 31.7 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -104.08 93.54 2.68 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.885 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.159 -173.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.565 0 CA-C-N 116.152 -0.476 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.6 m -77.54 146.32 36.39 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -75.14 -55.24 5.93 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.026 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.76 107.23 7.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.1 t80 -62.3 -45.49 92.99 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.984 -175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -57.7 -34.32 69.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.393 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.97 -28.42 64.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.577 0.751 . . . . 0.0 111.065 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -74.95 -18.49 60.38 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.268 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 -157.35 16.55 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.35 113.92 27.02 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.598 0.199 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 76.6 t80 63.92 95.45 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.106 1.362 . . . . 0.0 113.724 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.7 mm? -132.73 160.44 36.8 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -106.64 149.8 26.85 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.1 m -101.14 132.87 46.41 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 120.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.77 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.345 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 68.22 19.99 8.95 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.643 1.577 . . . . 0.0 111.187 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.37 6.19 74.6 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.7 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.04 144.32 23.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.0 m -83.05 109.78 17.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.92 134.89 25.7 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.79 158.03 31.46 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.673 1.582 . . . . 0.0 110.155 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.5 tpt -87.53 150.58 23.63 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 tp -106.14 90.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 121.548 0.689 . . . . 0.0 110.844 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.192 0 CA-C-N 116.111 -0.495 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.428 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . . . . . . 0 N--CA 1.444 -0.753 0 CA-C-O 120.998 0.428 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.446 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 60.7 m -90.66 145.89 24.47 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 172.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.28 -56.17 25.35 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.402 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -107.9 80.92 1.43 Allowed 'General case' 0 N--CA 1.414 -2.269 0 CA-C-O 122.816 1.293 . . . . 0.0 111.545 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -64.49 -45.69 86.21 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.853 -174.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -65.43 -25.34 67.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.137 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -84.07 -50.98 7.47 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.538 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.402 ' SG ' ' HG2' ' A' ' 4' ' ' GLU . 54.5 m -71.96 -42.96 65.94 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.626 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.51 159.3 25.77 Favored Glycine 0 C--O 1.254 1.392 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.577 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.94 4.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.942 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 179.22 -32.36 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 125.192 1.397 . . . . 0.0 107.501 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.02 149.32 27.03 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.036 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.49 146.34 24.16 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.1 m -101.36 120.73 40.72 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -132.88 111.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 65.84 22.63 11.42 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.266 1.426 . . . . 0.0 111.04 -176.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 1' ' ' ALA . . . 88.79 -6.77 83.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.807 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.82 135.73 25.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 2' ' ' CYS . 20.1 m -82.02 110.0 16.87 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.38 152.08 77.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.412 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.98 145.64 25.11 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.872 1.714 . . . . 0.0 108.372 170.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.2 ttp -86.72 149.05 25.15 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.051 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.8 tt -130.42 94.7 2.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.607 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.204 0 O-C-N 121.968 -0.457 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.844 0.354 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.1 m -81.4 123.45 28.57 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -77.9 -55.21 5.5 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.49 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -118.45 141.86 48.14 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.12 -48.76 6.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -50.28 -44.66 53.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.53 1.532 . . . . 0.0 113.638 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.58 -26.15 63.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.124 0.964 . . . . 0.0 110.596 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.485 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 59.4 m -92.64 -30.68 15.47 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.005 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.32 -146.48 18.15 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.38 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.49 122.04 46.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 60.42 101.01 0.02 OUTLIER 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.84 1.256 . . . . 0.0 111.135 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -135.36 162.95 31.16 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.356 -175.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.66 141.68 44.96 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 12' ' ' LEU . 76.0 m -116.66 138.35 51.51 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.64 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.43 106.03 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.184 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 63.34 26.32 14.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.187 1.395 . . . . 0.0 112.317 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 1' ' ' ALA . . . 99.66 -17.77 57.05 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.376 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.38 132.27 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 m -98.92 150.02 22.35 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.029 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.03 120.17 30.44 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.61 165.33 27.81 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.461 2.108 . . . . 0.0 113.277 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -53.16 141.57 22.86 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.439 1.095 . . . . 0.0 110.453 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.6 mt -106.58 97.3 5.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.15 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.495 0 CA-C-N 116.252 -0.431 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.94 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.7 m -73.18 122.07 21.3 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.4 -55.39 4.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -104.63 89.43 3.19 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -79.09 -38.74 35.52 Favored 'General case' 0 C--N 1.261 -3.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.962 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -52.81 -33.91 51.35 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.783 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.28 -31.33 65.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.613 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.2 m -81.35 -41.26 22.28 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.39 161.53 14.57 Favored Glycine 0 N--CA 1.417 -2.575 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.058 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.52 126.28 28.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 80.8 7.57 1.3 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.119 1.368 . . . . 0.0 113.165 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 12' ' ' LEU . 20.4 tp -94.31 101.78 13.75 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.7 153.79 25.15 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.268 -171.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 56.6 m -100.13 127.87 46.3 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -124.64 110.45 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 67.87 23.06 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.704 1.602 . . . . 0.0 109.8 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.29 -20.52 42.41 Favored Glycine 0 C--N 1.309 -0.965 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.022 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 48.3 mm -96.19 138.69 20.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.0 m -81.16 108.99 15.28 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.05 125.16 30.69 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.516 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.6 135.1 15.88 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.127 1.884 . . . . 0.0 111.102 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.98 157.6 34.71 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.0 mt -86.64 99.28 7.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 120.935 0.398 . . . . 0.0 110.265 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 116.393 -0.367 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m -77.88 149.99 34.2 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.96 -42.11 9.64 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 40.5 mt-10 -107.75 115.63 30.5 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -53.9 -49.56 68.33 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.869 0.842 . . . . 0.0 111.166 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.477 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 37.7 p90 -63.4 -9.88 14.37 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.945 -1.48 . . . . 0.0 114.349 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.63 -56.7 12.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.552 0.691 . . . . 0.0 110.818 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.48 -25.83 5.93 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.222 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.13 152.64 15.25 Favored Glycine 0 C--O 1.247 0.925 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -174.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.72 93.61 8.48 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.606 0.717 . . . . 0.0 110.6 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -172.96 -45.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.45 162.9 17.02 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 71.3 m-85 -98.32 168.76 10.02 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 m -138.61 120.42 15.34 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.348 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.477 HG23 ' HB ' ' A' ' 18' ' ' ILE . 10.2 tt -98.28 91.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 CA-C-O 122.786 1.279 . . . . 0.0 108.234 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.19 28.09 17.64 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.514 -2.13 . . . . 0.0 112.056 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.99 -16.01 23.18 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.443 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 15' ' ' ILE . 50.9 mm -86.74 133.49 29.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -81.76 131.28 35.26 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.06 0.457 . . . . 0.0 110.355 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 13' ' ' PHE . 61.6 t -99.74 123.44 47.68 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.96 134.95 67.23 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.543 2.829 . . . . 0.0 113.979 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.6 tpt -81.1 144.96 31.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.429 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.3 89.03 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.688 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 116.236 -0.438 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 56.8 m -100.17 153.78 18.98 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -56.9 -39.55 74.61 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 7' ' ' GLU . 9.4 tp10 -165.79 146.6 6.84 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 168.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -77.92 -53.28 7.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.577 0.703 . . . . 0.0 111.547 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -68.82 -26.19 65.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 9.4 pt-20 -72.16 -27.68 62.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.401 0.62 . . . . 0.0 110.868 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.2 m -83.57 -39.4 20.42 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.507 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.29 -146.25 18.21 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.3 122.37 46.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 57.29 82.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.906 1.282 . . . . 0.0 114.088 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.65 131.62 53.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.43 118.08 24.74 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 60.2 m -100.83 144.87 29.26 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.831 -171.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.2 mt -139.5 121.3 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 68.59 22.18 7.71 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.397 1.479 . . . . 0.0 109.772 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -15.98 59.89 Favored Glycine 0 C--N 1.305 -1.158 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.705 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.42 131.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 58.0 m -81.36 109.63 16.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.58 110.76 62.66 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.144 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.68 160.63 19.13 Favored 'Trans proline' 0 N--CA 1.432 -2.137 0 C-N-CA 121.766 1.644 . . . . 0.0 110.999 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 55.0 ttp -61.47 155.7 21.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.08 91.3 3.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.098 0 CA-C-N 116.102 -0.499 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 80.3 m -81.78 147.45 29.41 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 123.162 0.288 . . . . 0.0 110.676 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -79.75 -33.49 40.68 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.286 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -73.8 78.37 1.59 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.325 1.06 . . . . 0.0 112.055 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -72.17 -44.1 63.57 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.09 -1.413 . . . . 0.0 108.251 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -60.05 -35.05 74.28 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.59 -49.41 12.23 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.23 -42.24 55.74 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.075 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.09 -170.43 15.03 Favored Glycine 0 C--N 1.299 -1.499 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 95.16 1.47 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 60.47 85.77 0.11 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.38 156.47 23.4 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 22' ' ' MET . 82.8 m-85 -100.12 163.75 12.28 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.6 m -123.33 137.6 54.8 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.162 -1.015 . . . . 0.0 113.507 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.27 105.03 13.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 66.34 22.12 10.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 126.314 1.845 . . . . 0.0 110.534 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.82 -7.55 63.06 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.918 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mm -87.08 125.41 40.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 79.3 m -81.3 121.6 26.39 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.461 0.476 . . . . 0.0 110.261 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.54 160.09 66.6 Favored Pre-proline 0 C--N 1.305 -1.339 0 C-N-CA 124.033 0.933 . . . . 0.0 108.987 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.32 137.97 49.27 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.483 1.456 . . . . 0.0 109.022 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.565 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . 54.6 ttp -63.4 135.53 57.02 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.981 0.896 . . . . 0.0 112.593 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -94.29 98.91 8.67 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.528 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.569 0 CA-C-N 116.549 -0.296 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.273 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.6 m -72.98 144.82 47.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.786 0.327 . . . . 0.0 110.735 -178.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -77.56 -42.62 34.67 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -89.88 88.25 7.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.254 176.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 26.3 t80 -85.2 -27.81 25.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -61.18 -25.25 66.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.646 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.35 -33.14 69.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.95 0.881 . . . . 0.0 109.484 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 59.3 m -76.19 -43.42 42.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.527 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.76 -148.1 18.91 Favored Glycine 0 C--N 1.298 -1.53 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.42 105.91 17.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.065 -178.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 97.7 m-85 65.45 86.61 0.13 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.692 1.197 . . . . 0.0 114.094 175.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 3.7 mm? -136.39 162.91 31.73 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.215 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -108.25 154.02 22.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.59 139.22 50.75 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.391 0.615 . . . . 0.0 111.699 -178.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 tt -140.19 108.97 3.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.278 175.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 61.38 26.94 16.64 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.105 1.362 . . . . 0.0 112.071 178.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.81 -9.85 64.13 Favored Glycine 0 C--N 1.313 -0.713 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.187 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.12 128.38 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.0 m -87.59 118.06 26.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.0 m -120.99 140.06 30.27 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.591 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 20' ' ' VAL . 14.2 Cg_exo -69.51 116.54 4.58 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 122.38 2.053 . . . . 0.0 110.958 175.224 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -98.98 156.39 16.94 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 tt -116.03 92.72 2.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.75 0.786 . . . . 0.0 110.501 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 115.87 -0.604 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 96.1 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 120.501 0.191 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -60.1 -52.54 64.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.853 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -93.96 101.98 14.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.35 -42.91 95.99 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.72 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -63.66 -18.91 64.45 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.983 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.48 -36.42 78.92 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.053 0.93 . . . . 0.0 108.501 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -82.45 -43.5 17.18 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.805 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.71 -131.31 9.26 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.02 106.74 16.81 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.1 0.45 . . . . 0.0 110.746 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.406 ' C ' HD22 ' A' ' 12' ' ' LEU . 87.7 t80 53.32 94.46 0.02 OUTLIER 'General case' 0 C--O 1.246 0.89 0 C-N-CA 125.323 1.449 . . . . 0.0 113.899 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.8 mm? -131.8 163.35 28.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -99.49 129.79 45.69 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.6 m -100.34 126.95 46.75 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 122.363 1.077 . . . . 0.0 111.475 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tt -128.21 100.13 5.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.536 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 59.89 34.54 21.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.856 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.58 -10.18 60.89 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.153 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.53 122.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.2 m -87.62 109.98 20.06 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.17 152.77 43.99 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.445 -1.362 0 C-N-CA 121.221 1.281 . . . . 0.0 109.898 175.351 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -96.81 -21.87 17.27 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.836 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.63 95.2 3.55 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.739 0.781 . . . . 0.0 109.115 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.488 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.9 t80 -61.89 -46.42 89.47 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.458 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -65.69 -19.97 66.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.15 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.35 -18.33 60.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 109.703 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.9 m -100.5 4.92 43.98 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.154 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.41 -147.22 17.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.707 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.82 128.66 56.5 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 122.384 0.273 . . . . 0.0 110.395 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 47.0 t80 54.09 99.48 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.051 1.74 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -132.59 156.56 46.67 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 130.48 56.39 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -101.38 137.81 39.22 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.9 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 tp -153.31 122.77 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 65.57 20.91 11.7 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.731 1.213 . . . . 0.0 110.953 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.34 -3.81 82.23 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.957 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.65 132.06 40.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.55 116.31 22.51 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.49 121.24 34.91 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.368 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.446 -1.314 0 C-N-CA 122.229 1.952 . . . . 0.0 110.816 173.874 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HB3' ' OE2' ' A' ' 7' ' ' GLU . 34.9 m . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.09 -48.51 17.6 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.937 -173.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 70.1 mm-40 -122.95 160.2 26.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.79 -45.72 34.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.291 1.043 . . . . 0.0 108.478 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.8 p-90 -68.38 -9.8 50.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.439 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 2' ' ' CYS . 42.2 tt0 -63.95 -36.99 85.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.831 0.824 . . . . 0.0 109.003 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 72.5 m -92.82 -43.83 8.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.995 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.26 177.62 14.96 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.869 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.62 122.42 19.06 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 68.42 16.0 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.491 1.116 . . . . 0.0 112.737 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -103.53 102.67 12.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.95 168.9 11.08 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.44 128.84 47.47 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.14 111.99 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 65.62 21.57 11.68 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 126.649 1.979 . . . . 0.0 111.003 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.38 -2.47 74.37 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.961 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.93 137.49 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 38.0 m -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -140.41 153.05 68.15 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 C-N-CA 121.629 1.553 . . . . 0.0 109.425 175.266 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.2 m . . . . . 0 N--CA 1.439 -0.992 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.49 -55.66 2.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -135.68 104.69 5.87 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.39 -48.09 83.25 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.66 0.743 . . . . 0.0 110.336 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -61.89 -27.07 68.55 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.165 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -71.58 -30.74 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.1 0.953 . . . . 0.0 109.693 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.16 -42.57 10.98 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.718 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.51 -177.37 16.51 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.93 140.91 29.94 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 72.89 16.82 4.41 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.07 145.93 28.99 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -111.93 141.76 45.17 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.03 127.79 47.38 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-O 122.085 0.945 . . . . 0.0 110.807 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -135.83 114.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 66.65 24.48 10.07 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 125.401 1.481 . . . . 0.0 110.85 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.46 0.46 89.37 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.109 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.6 mt -105.42 139.38 26.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.12 114.46 25.73 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.979 0.419 . . . . 0.0 110.327 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.09 133.68 23.4 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--O 1.241 0.625 0 C-N-CA 122.009 1.806 . . . . 0.0 109.816 174.807 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.245 0.834 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -105.03 -56.17 2.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.947 0.403 . . . . 0.0 111.2 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -121.41 130.27 53.5 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.262 0.553 . . . . 0.0 110.692 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -63.61 -45.31 90.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.777 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -68.06 -16.76 64.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.175 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.08 -32.82 71.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.67 0.748 . . . . 0.0 109.123 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.3 m -85.03 -37.59 20.18 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.906 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.85 -60.3 0.57 Allowed Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.6 174.87 5.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -74.13 99.13 3.29 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.487 1.137 . . . . 0.0 111.2 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.4 tp -129.37 156.19 44.45 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.394 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 93.5 m-85 -82.7 141.92 32.06 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.687 0.28 . . . . 0.0 110.468 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -106.69 130.87 54.35 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.409 0.623 . . . . 0.0 109.851 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 112.08 20.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 63.44 24.04 13.96 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.562 1.145 . . . . 0.0 112.77 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.59 75.25 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.426 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mt -106.4 127.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 11.3 m -83.17 112.3 19.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.63 138.01 31.67 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--O 1.253 1.243 0 C-N-CA 122.257 1.971 . . . . 0.0 110.268 174.433 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -72.3 -56.16 5.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.46 124.24 19.86 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -56.08 -52.46 64.22 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 123.664 0.786 . . . . 0.0 110.841 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -63.55 -17.07 62.43 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 124.648 1.179 . . . . 0.0 113.448 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.68 -22.46 56.67 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.804 0.812 . . . . 0.0 109.739 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.1 m -120.23 -42.68 2.56 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.574 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.65 -161.66 12.63 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.62 155.07 18.08 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 122.521 0.328 . . . . 0.0 110.249 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 68.83 14.01 8.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.37 140.74 32.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.85 107.54 18.73 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 67.7 m -101.35 141.76 33.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.705 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 tt -144.73 114.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 64.83 22.57 12.54 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.973 1.309 . . . . 0.0 111.899 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.49 -18.0 49.09 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.976 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 46.5 mm -85.95 130.51 36.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 m -96.49 111.15 23.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.63 115.23 60.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.108 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 N--CA 1.443 -1.48 0 N-CA-C 107.718 -1.685 . . . . 0.0 107.718 170.554 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 46.2 m . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -97.89 -55.42 2.8 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.46 82.72 1.64 Allowed 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 122.849 1.309 . . . . 0.0 111.653 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.13 -40.89 82.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.842 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -63.8 -22.85 67.11 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.565 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -91.11 -17.97 25.29 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.943 0.877 . . . . 0.0 109.594 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.83 -38.7 11.61 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.068 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.7 171.95 14.18 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.3 36.02 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.457 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 72.86 28.14 2.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.035 1.334 . . . . 0.0 112.158 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 3.9 mm? -91.33 119.35 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.425 173.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -95.17 156.38 16.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.38 152.92 31.97 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.487 0.661 . . . . 0.0 112.782 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.1 mt -143.0 119.13 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 71.33 11.1 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.274 1.43 . . . . 0.0 111.349 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.23 70.57 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.9 mt -97.0 126.74 49.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 20.4 m -80.89 116.36 20.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.96 131.09 22.39 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-O 121.213 0.53 . . . . 0.0 111.768 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.439 -1.691 0 C-N-CA 122.168 1.912 . . . . 0.0 110.685 172.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.239 0.545 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -106.07 -55.69 2.29 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.944 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -134.33 112.54 11.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.692 0.797 . . . . 0.0 109.524 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -63.3 -42.99 99.09 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.47 1.108 . . . . 0.0 111.366 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -59.92 -26.66 66.12 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.385 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.23 -19.64 42.75 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.705 0.802 . . . . 0.0 111.513 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 82.7 m -100.68 -39.35 7.9 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.786 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.41 -140.37 11.81 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.401 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.57 118.73 35.89 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.635 0.217 . . . . 0.0 111.231 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 47.72 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.503 1.521 . . . . 0.0 112.724 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' A' ' 8' ' ' CYS . 1.4 mm? -118.5 163.61 16.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.645 -174.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 20' ' ' VAL . 54.1 t80 -102.57 115.42 30.55 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 173.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 m -101.63 132.25 47.41 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.44 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.5 tt -131.4 105.82 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 CA-C-O 121.895 0.855 . . . . 0.0 109.746 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 65.01 21.02 12.24 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.859 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.13 -8.07 41.45 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.912 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.48 119.4 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -92.89 118.85 31.59 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 13' ' ' PHE . 27.5 m -104.4 153.81 38.81 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 N--CA 1.459 -0.502 0 C-N-CA 121.992 1.795 . . . . 0.0 110.289 178.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -96.99 -56.35 2.58 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.948 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.17 97.77 8.55 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.88 -52.24 60.88 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.941 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -57.34 -25.16 58.96 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 126.425 1.89 . . . . 0.0 113.234 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -70.6 -30.56 67.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.297 1.046 . . . . 0.0 109.444 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 64.3 m -97.98 -42.34 7.56 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.607 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.6 -173.32 20.15 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.81 33.7 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.712 0.292 . . . . 0.0 110.916 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 69.39 23.59 6.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.219 1.408 . . . . 0.0 112.016 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.33 118.3 23.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.564 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.5 m -100.8 140.62 34.82 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 tt -126.76 109.78 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 70.88 19.4 5.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.442 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 -20.91 45.65 Favored Glycine 0 C--O 1.236 0.226 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.11 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.19 127.81 41.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 m -81.99 109.64 16.51 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -101.32 126.05 35.82 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo . . . . . 0 C--N 1.36 1.162 0 C-N-CA 123.385 2.723 . . . . 0.0 111.164 178.134 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -80.05 -55.96 4.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.262 0.553 . . . . 0.0 109.556 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -136.2 106.09 6.25 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.167 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.29 -46.81 85.02 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.17 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -60.19 -29.65 68.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.823 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.34 -44.4 75.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.63 0.729 . . . . 0.0 109.922 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.5 m -77.48 -39.57 46.0 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.804 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.36 165.34 12.06 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.41 142.86 35.57 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 69.12 25.25 5.84 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.545 1.138 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.33 149.61 22.25 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.4 143.18 45.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.3 m -106.54 133.54 51.07 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.393 0.616 . . . . 0.0 110.624 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 tt -145.31 114.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 63.28 23.47 13.83 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.753 1.221 . . . . 0.0 112.106 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.99 69.92 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -100.55 124.09 53.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -89.6 109.96 20.87 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.86 129.28 6.77 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 N--CA 1.444 -1.41 0 C-N-CA 122.11 1.873 . . . . 0.0 111.408 -179.017 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.5 m . . . . . 0 C--O 1.237 0.447 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 34.9 mtmm -79.95 -55.5 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 45.0 mm-40 -117.57 156.27 28.38 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -70.44 -59.09 3.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.772 0.796 . . . . 0.0 111.394 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -60.94 -15.19 28.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.602 1.161 . . . . 0.0 112.646 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.7 tt0 -55.68 -41.62 73.97 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 124.841 1.257 . . . . 0.0 110.334 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.0 m -106.55 -30.46 9.03 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.536 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.95 -165.47 12.04 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.85 132.53 33.8 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 120.644 0.259 . . . . 0.0 111.096 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 70.04 16.42 7.55 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.142 1.377 . . . . 0.0 114.549 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.94 142.57 27.89 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -95.34 115.65 27.71 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.4 m -100.42 126.66 46.84 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.3 -175.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.3 mt -113.19 104.84 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.569 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 65.44 25.13 11.94 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 125.486 1.514 . . . . 0.0 111.854 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.2 -8.75 57.46 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.214 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 81.3 mt -92.01 134.17 31.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.39 114.9 22.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.228 0.537 . . . . 0.0 109.934 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.96 144.84 44.1 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 C--O 1.247 0.94 0 C-N-CA 122.108 1.872 . . . . 0.0 111.335 175.008 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -78.14 -55.82 4.96 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.408 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.35 140.12 39.33 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -54.61 -52.73 61.3 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.322 1.449 . . . . 0.0 111.258 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -63.54 -23.77 67.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.604 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.93 -26.89 62.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.155 0.979 . . . . 0.0 109.831 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 58.5 m -102.34 5.04 39.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.399 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.24 -81.56 1.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.71 175.83 5.27 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.98 118.3 7.62 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 33.0 tp -136.66 162.36 33.38 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -82.66 137.42 34.48 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 57.3 m -114.07 142.36 46.29 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.72 110.51 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 62.61 25.79 15.32 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.63 -15.05 56.18 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.083 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 70.9 mt -89.26 117.42 32.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.75 109.23 15.96 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.85 125.31 38.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo . . . . . 0 C--N 1.353 0.815 0 C-N-CA 123.659 2.906 . . . . 0.0 111.683 177.104 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 84.9 m . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.33 -54.14 7.58 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -82.14 95.92 7.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -74.63 -44.14 51.98 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.925 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -59.93 -25.63 65.32 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.099 -1.41 . . . . 0.0 112.268 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.78 -18.5 64.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.788 0.804 . . . . 0.0 110.312 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 59.6 m -98.02 -1.59 42.25 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.79 -149.12 29.57 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.216 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.58 111.33 22.89 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.803 0.302 . . . . 0.0 111.518 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 50.01 80.89 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.14 1.376 . . . . 0.0 113.772 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 17.0 tp -131.07 136.88 48.82 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 86.9 m-85 -82.75 154.75 24.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.487 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.4 m -100.97 132.12 46.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.406 ' HB ' HG12 ' A' ' 20' ' ' VAL . 45.7 mm -137.69 117.53 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 65.93 19.52 11.26 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 125.404 1.482 . . . . 0.0 112.074 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.7 -8.9 60.14 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.491 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.7 mt -115.54 145.44 21.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 67.4 m -83.89 129.49 34.93 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.121 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.406 HG12 ' HB ' ' A' ' 15' ' ' ILE . 14.5 p -142.03 141.04 20.55 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--O 1.24 0.622 0 C-N-CA 122.25 1.967 . . . . 0.0 112.657 178.888 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -75.14 -55.24 5.93 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.026 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.76 107.23 7.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.1 t80 -62.3 -45.49 92.99 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.984 -175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -57.7 -34.32 69.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.393 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.97 -28.42 64.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.577 0.751 . . . . 0.0 111.065 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -74.95 -18.49 60.38 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.268 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 -157.35 16.55 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.35 113.92 27.02 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.598 0.199 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 76.6 t80 63.92 95.45 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.106 1.362 . . . . 0.0 113.724 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.7 mm? -132.73 160.44 36.8 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -106.64 149.8 26.85 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.1 m -101.14 132.87 46.41 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 120.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.77 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.345 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 68.22 19.99 8.95 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.643 1.577 . . . . 0.0 111.187 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.37 6.19 74.6 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.7 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.04 144.32 23.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.0 m -83.05 109.78 17.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.92 134.89 25.7 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo . . . . . 0 N--CA 1.454 -0.83 0 C-N-CA 121.673 1.582 . . . . 0.0 110.155 173.771 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.446 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 60.7 m . . . . . 0 C--O 1.243 0.72 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.28 -56.17 25.35 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.402 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -107.9 80.92 1.43 Allowed 'General case' 0 N--CA 1.414 -2.269 0 CA-C-O 122.816 1.293 . . . . 0.0 111.545 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -64.49 -45.69 86.21 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.853 -174.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -65.43 -25.34 67.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.137 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -84.07 -50.98 7.47 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.538 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.402 ' SG ' ' HG2' ' A' ' 4' ' ' GLU . 54.5 m -71.96 -42.96 65.94 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.626 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.51 159.3 25.77 Favored Glycine 0 C--O 1.254 1.392 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.577 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.94 4.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.942 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 179.22 -32.36 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 125.192 1.397 . . . . 0.0 107.501 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.02 149.32 27.03 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.036 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.49 146.34 24.16 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.1 m -101.36 120.73 40.72 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -132.88 111.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 65.84 22.63 11.42 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.266 1.426 . . . . 0.0 111.04 -176.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.79 -6.77 83.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.807 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.82 135.73 25.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 2' ' ' CYS . 20.1 m -82.02 110.0 16.87 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.38 152.08 77.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.412 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo . . . . . 0 N--CA 1.45 -1.08 0 C-N-CA 121.872 1.714 . . . . 0.0 108.372 170.835 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -77.9 -55.21 5.5 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.49 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -118.45 141.86 48.14 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.12 -48.76 6.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -50.28 -44.66 53.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.53 1.532 . . . . 0.0 113.638 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.58 -26.15 63.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.124 0.964 . . . . 0.0 110.596 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.485 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 59.4 m -92.64 -30.68 15.47 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.005 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.32 -146.48 18.15 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.38 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.49 122.04 46.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 60.42 101.01 0.02 OUTLIER 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.84 1.256 . . . . 0.0 111.135 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -135.36 162.95 31.16 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.356 -175.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.66 141.68 44.96 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 12' ' ' LEU . 76.0 m -116.66 138.35 51.51 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.64 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.43 106.03 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.184 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 63.34 26.32 14.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.187 1.395 . . . . 0.0 112.317 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.66 -17.77 57.05 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.376 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.38 132.27 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 m -98.92 150.02 22.35 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.029 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.03 120.17 30.44 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.461 2.108 . . . . 0.0 113.277 -176.57 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.4 -55.39 4.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -104.63 89.43 3.19 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -79.09 -38.74 35.52 Favored 'General case' 0 C--N 1.261 -3.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.962 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -52.81 -33.91 51.35 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.783 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.28 -31.33 65.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.613 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.2 m -81.35 -41.26 22.28 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.39 161.53 14.57 Favored Glycine 0 N--CA 1.417 -2.575 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.058 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.52 126.28 28.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 80.8 7.57 1.3 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.119 1.368 . . . . 0.0 113.165 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 12' ' ' LEU . 20.4 tp -94.31 101.78 13.75 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.7 153.79 25.15 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.268 -171.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 56.6 m -100.13 127.87 46.3 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -124.64 110.45 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 67.87 23.06 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.704 1.602 . . . . 0.0 109.8 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.29 -20.52 42.41 Favored Glycine 0 C--N 1.309 -0.965 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.022 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 48.3 mm -96.19 138.69 20.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.0 m -81.16 108.99 15.28 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.05 125.16 30.69 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.516 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.448 -1.156 0 C-N-CA 122.127 1.884 . . . . 0.0 111.102 175.868 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.505 -0.778 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.96 -42.11 9.64 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 40.5 mt-10 -107.75 115.63 30.5 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -53.9 -49.56 68.33 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.869 0.842 . . . . 0.0 111.166 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.477 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 37.7 p90 -63.4 -9.88 14.37 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.945 -1.48 . . . . 0.0 114.349 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.63 -56.7 12.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.552 0.691 . . . . 0.0 110.818 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.48 -25.83 5.93 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.222 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.13 152.64 15.25 Favored Glycine 0 C--O 1.247 0.925 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -174.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.72 93.61 8.48 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.606 0.717 . . . . 0.0 110.6 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -172.96 -45.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.45 162.9 17.02 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 71.3 m-85 -98.32 168.76 10.02 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 m -138.61 120.42 15.34 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.348 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.477 HG23 ' HB ' ' A' ' 18' ' ' ILE . 10.2 tt -98.28 91.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 CA-C-O 122.786 1.279 . . . . 0.0 108.234 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.19 28.09 17.64 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.514 -2.13 . . . . 0.0 112.056 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.99 -16.01 23.18 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.443 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 15' ' ' ILE . 50.9 mm -86.74 133.49 29.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -81.76 131.28 35.26 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.06 0.457 . . . . 0.0 110.355 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 13' ' ' PHE . 61.6 t -99.74 123.44 47.68 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 C--O 1.245 0.867 0 C-N-CA 123.543 2.829 . . . . 0.0 113.979 -176.626 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 C--O 1.246 0.88 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -56.9 -39.55 74.61 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 7' ' ' GLU . 9.4 tp10 -165.79 146.6 6.84 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 168.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -77.92 -53.28 7.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.577 0.703 . . . . 0.0 111.547 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -68.82 -26.19 65.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 9.4 pt-20 -72.16 -27.68 62.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.401 0.62 . . . . 0.0 110.868 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.2 m -83.57 -39.4 20.42 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.507 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.29 -146.25 18.21 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.3 122.37 46.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 57.29 82.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.906 1.282 . . . . 0.0 114.088 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.65 131.62 53.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.43 118.08 24.74 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 60.2 m -100.83 144.87 29.26 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.831 -171.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.2 mt -139.5 121.3 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 68.59 22.18 7.71 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.397 1.479 . . . . 0.0 109.772 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -15.98 59.89 Favored Glycine 0 C--N 1.305 -1.158 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.705 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.42 131.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 58.0 m -81.36 109.63 16.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.58 110.76 62.66 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.144 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 N--CA 1.432 -2.137 0 C-N-CA 121.766 1.644 . . . . 0.0 110.999 176.849 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 80.3 m . . . . . 0 C--O 1.241 0.626 0 CA-C-O 120.491 0.186 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -79.75 -33.49 40.68 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.286 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -73.8 78.37 1.59 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.325 1.06 . . . . 0.0 112.055 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -72.17 -44.1 63.57 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.09 -1.413 . . . . 0.0 108.251 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -60.05 -35.05 74.28 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.59 -49.41 12.23 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.23 -42.24 55.74 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.075 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.09 -170.43 15.03 Favored Glycine 0 C--N 1.299 -1.499 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 95.16 1.47 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 60.47 85.77 0.11 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.38 156.47 23.4 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 82.8 m-85 -100.12 163.75 12.28 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.6 m -123.33 137.6 54.8 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.162 -1.015 . . . . 0.0 113.507 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.27 105.03 13.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 66.34 22.12 10.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 126.314 1.845 . . . . 0.0 110.534 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.82 -7.55 63.06 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.918 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mm -87.08 125.41 40.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 79.3 m -81.3 121.6 26.39 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.461 0.476 . . . . 0.0 110.261 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.54 160.09 66.6 Favored Pre-proline 0 C--N 1.305 -1.339 0 C-N-CA 124.033 0.933 . . . . 0.0 108.987 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--O 1.243 0.77 0 C-N-CA 121.483 1.456 . . . . 0.0 109.022 170.583 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 CA--C 1.517 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -77.56 -42.62 34.67 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -89.88 88.25 7.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.254 176.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 26.3 t80 -85.2 -27.81 25.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -61.18 -25.25 66.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.646 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.35 -33.14 69.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.95 0.881 . . . . 0.0 109.484 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 59.3 m -76.19 -43.42 42.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.527 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.76 -148.1 18.91 Favored Glycine 0 C--N 1.298 -1.53 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.42 105.91 17.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.065 -178.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 97.7 m-85 65.45 86.61 0.13 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.692 1.197 . . . . 0.0 114.094 175.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 3.7 mm? -136.39 162.91 31.73 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.215 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -108.25 154.02 22.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.59 139.22 50.75 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.391 0.615 . . . . 0.0 111.699 -178.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 tt -140.19 108.97 3.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.278 175.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 61.38 26.94 16.64 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.105 1.362 . . . . 0.0 112.071 178.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.81 -9.85 64.13 Favored Glycine 0 C--N 1.313 -0.713 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.187 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.12 128.38 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.0 m -87.59 118.06 26.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.0 m -120.99 140.06 30.27 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.591 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 20' ' ' VAL . 14.2 Cg_exo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 122.38 2.053 . . . . 0.0 110.958 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.487 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 96.1 m -58.58 157.32 9.3 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.345 0.658 . . . . 0.0 110.604 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -60.1 -52.54 64.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.853 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -93.96 101.98 14.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.35 -42.91 95.99 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.72 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -63.66 -18.91 64.45 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.983 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.48 -36.42 78.92 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.053 0.93 . . . . 0.0 108.501 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -82.45 -43.5 17.18 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.805 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.71 -131.31 9.26 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.02 106.74 16.81 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 117.1 0.45 . . . . 0.0 110.746 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.406 ' C ' HD22 ' A' ' 12' ' ' LEU . 87.7 t80 53.32 94.46 0.02 OUTLIER 'General case' 0 C--O 1.246 0.89 0 C-N-CA 125.323 1.449 . . . . 0.0 113.899 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.8 mm? -131.8 163.35 28.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -99.49 129.79 45.69 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.6 m -100.34 126.95 46.75 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 122.363 1.077 . . . . 0.0 111.475 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tt -128.21 100.13 5.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.536 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 59.89 34.54 21.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.856 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.58 -10.18 60.89 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.153 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.53 122.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.2 m -87.62 109.98 20.06 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.17 152.77 43.99 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.37 130.96 18.15 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 121.221 1.281 . . . . 0.0 109.898 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.9 ttp -78.25 149.56 33.58 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.005 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mp -97.98 -80.43 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.898 0 O-C-N 122.22 -0.3 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 69.0 m -78.47 130.76 36.42 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -96.81 -21.87 17.27 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.836 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.63 95.2 3.55 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.739 0.781 . . . . 0.0 109.115 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.488 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.9 t80 -61.89 -46.42 89.47 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.458 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -65.69 -19.97 66.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.718 -1.583 . . . . 0.0 112.15 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.35 -18.33 60.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 109.703 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.9 m -100.5 4.92 43.98 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.154 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.41 -147.22 17.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.707 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.82 128.66 56.5 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 122.384 0.273 . . . . 0.0 110.395 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 47.0 t80 54.09 99.48 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.051 1.74 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -132.59 156.56 46.67 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 130.48 56.39 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -101.38 137.81 39.22 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.9 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 tp -153.31 122.77 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 65.57 20.91 11.7 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.731 1.213 . . . . 0.0 110.953 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.34 -3.81 82.23 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.957 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.65 132.06 40.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.55 116.31 22.51 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.49 121.24 34.91 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.368 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -84.84 137.5 6.53 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.229 1.952 . . . . 0.0 110.816 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.07 155.23 27.64 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.0 mt -83.0 -84.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.937 0 O-C-N 122.08 -0.387 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.645 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HB3' ' OE2' ' A' ' 7' ' ' GLU . 34.9 m -75.04 170.14 16.6 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.09 -48.51 17.6 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.937 -173.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 70.1 mm-40 -122.95 160.2 26.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.79 -45.72 34.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.291 1.043 . . . . 0.0 108.478 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.8 p-90 -68.38 -9.8 50.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.439 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 2' ' ' CYS . 42.2 tt0 -63.95 -36.99 85.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.831 0.824 . . . . 0.0 109.003 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 72.5 m -92.82 -43.83 8.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.995 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.26 177.62 14.96 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.869 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.62 122.42 19.06 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 68.42 16.0 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.491 1.116 . . . . 0.0 112.737 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -103.53 102.67 12.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.95 168.9 11.08 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.44 128.84 47.47 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.547 0.689 . . . . 0.0 110.219 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.14 111.99 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 65.62 21.57 11.68 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 126.649 1.979 . . . . 0.0 111.003 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.38 -2.47 74.37 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.961 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.93 137.49 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 38.0 m -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -140.41 153.05 68.15 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.95 130.98 16.23 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.629 1.553 . . . . 0.0 109.425 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.6 ttt -77.81 140.97 39.46 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 tp -124.65 -62.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.93 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.164 0 O-C-N 121.919 -0.488 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.901 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.2 m -99.78 147.59 25.31 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.49 -55.66 2.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -135.68 104.69 5.87 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.39 -48.09 83.25 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.66 0.743 . . . . 0.0 110.336 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -61.89 -27.07 68.55 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.165 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -71.58 -30.74 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.1 0.953 . . . . 0.0 109.693 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.16 -42.57 10.98 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.718 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.51 -177.37 16.51 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.93 140.91 29.94 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 72.89 16.82 4.41 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.07 145.93 28.99 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -111.93 141.76 45.17 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.03 127.79 47.38 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-O 122.085 0.945 . . . . 0.0 110.807 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -135.83 114.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 66.65 24.48 10.07 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 125.401 1.481 . . . . 0.0 110.85 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.46 0.46 89.37 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.109 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.6 mt -105.42 139.38 26.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.12 114.46 25.73 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.979 0.419 . . . . 0.0 110.327 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.09 133.68 23.4 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.06 129.83 19.08 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 122.009 1.806 . . . . 0.0 109.816 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.6 tpt -102.73 151.51 22.31 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-O 121.032 0.444 . . . . 0.0 110.727 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tt -95.65 93.99 4.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.125 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.576 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.4 m -66.36 142.54 57.59 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 123.233 0.333 . . . . 0.0 110.539 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -105.03 -56.17 2.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.947 0.403 . . . . 0.0 111.2 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -121.41 130.27 53.5 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.262 0.553 . . . . 0.0 110.692 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -63.61 -45.31 90.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.777 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -68.06 -16.76 64.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.175 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.08 -32.82 71.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.67 0.748 . . . . 0.0 109.123 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.3 m -85.03 -37.59 20.18 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.906 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.85 -60.3 0.57 Allowed Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.6 174.87 5.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -74.13 99.13 3.29 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.487 1.137 . . . . 0.0 111.2 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.4 tp -129.37 156.19 44.45 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.394 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 93.5 m-85 -82.7 141.92 32.06 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.687 0.28 . . . . 0.0 110.468 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -106.69 130.87 54.35 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.409 0.623 . . . . 0.0 109.851 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 112.08 20.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 63.44 24.04 13.96 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.562 1.145 . . . . 0.0 112.77 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.59 75.25 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.426 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mt -106.4 127.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 11.3 m -83.17 112.3 19.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.63 138.01 31.67 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.73 122.39 11.72 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 122.257 1.971 . . . . 0.0 110.268 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.6 ttt -63.11 143.83 57.44 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.487 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -87.03 -73.94 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.143 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.153 0 O-C-N 122.37 -0.207 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.8 m -100.06 166.68 10.91 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -72.3 -56.16 5.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.46 124.24 19.86 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -56.08 -52.46 64.22 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 123.664 0.786 . . . . 0.0 110.841 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -63.55 -17.07 62.43 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 124.648 1.179 . . . . 0.0 113.448 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.68 -22.46 56.67 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.804 0.812 . . . . 0.0 109.739 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.1 m -120.23 -42.68 2.56 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.574 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.65 -161.66 12.63 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.62 155.07 18.08 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 122.521 0.328 . . . . 0.0 110.249 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 68.83 14.01 8.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.37 140.74 32.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.85 107.54 18.73 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 67.7 m -101.35 141.76 33.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.705 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.9 tt -144.73 114.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 64.83 22.57 12.54 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.973 1.309 . . . . 0.0 111.899 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.49 -18.0 49.09 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.976 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 46.5 mm -85.95 130.51 36.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 m -96.49 111.15 23.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.63 115.23 60.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.108 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.32 112.26 2.95 Favored 'Trans proline' 0 N--CA 1.443 -1.48 0 N-CA-C 107.718 -1.685 . . . . 0.0 107.718 170.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 54.7 ttp -75.36 138.81 42.01 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 121.236 0.541 . . . . 0.0 110.041 -175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 tp -133.14 105.22 7.77 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.278 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.155 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.455 0 CA-C-N 116.119 -0.491 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.613 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 46.2 m -80.51 129.72 34.69 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -97.89 -55.42 2.8 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.46 82.72 1.64 Allowed 'General case' 0 N--CA 1.412 -2.363 0 CA-C-O 122.849 1.309 . . . . 0.0 111.653 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.13 -40.89 82.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.842 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -63.8 -22.85 67.11 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.565 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -91.11 -17.97 25.29 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.943 0.877 . . . . 0.0 109.594 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.83 -38.7 11.61 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.068 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.7 171.95 14.18 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.3 36.02 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.457 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 72.86 28.14 2.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.035 1.334 . . . . 0.0 112.158 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 3.9 mm? -91.33 119.35 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.425 173.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -95.17 156.38 16.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.38 152.92 31.97 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.487 0.661 . . . . 0.0 112.782 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.1 mt -143.0 119.13 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 71.33 11.1 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.274 1.43 . . . . 0.0 111.349 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.23 70.57 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.9 mt -97.0 126.74 49.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 20.4 m -80.89 116.36 20.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.96 131.09 22.39 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-O 121.213 0.53 . . . . 0.0 111.768 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.59 144.44 11.29 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 122.168 1.912 . . . . 0.0 110.685 172.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.4 ttt -83.79 152.52 24.59 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.379 0.609 . . . . 0.0 110.665 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 tp -82.31 96.37 3.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.867 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.242 0 CA-C-N 115.975 -0.557 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 120.529 0.204 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.8 m -97.84 143.99 27.88 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -106.07 -55.69 2.29 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.944 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -134.33 112.54 11.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 123.692 0.797 . . . . 0.0 109.524 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -63.3 -42.99 99.09 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.47 1.108 . . . . 0.0 111.366 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -59.92 -26.66 66.12 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.385 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.23 -19.64 42.75 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.705 0.802 . . . . 0.0 111.513 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 82.7 m -100.68 -39.35 7.9 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.786 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.41 -140.37 11.81 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.401 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.57 118.73 35.89 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.635 0.217 . . . . 0.0 111.231 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 47.72 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.503 1.521 . . . . 0.0 112.724 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' A' ' 8' ' ' CYS . 1.4 mm? -118.5 163.61 16.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.645 -174.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 20' ' ' VAL . 54.1 t80 -102.57 115.42 30.55 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 173.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 m -101.63 132.25 47.41 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.44 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.5 tt -131.4 105.82 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 CA-C-O 121.895 0.855 . . . . 0.0 109.746 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 65.01 21.02 12.24 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.514 -1.675 . . . . 0.0 111.859 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.13 -8.07 41.45 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.912 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.48 119.4 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -92.89 118.85 31.59 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 13' ' ' PHE . 27.5 m -104.4 153.81 38.81 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.2 121.97 10.44 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 121.992 1.795 . . . . 0.0 110.289 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.1 tpt -69.51 137.63 52.67 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.607 0.718 . . . . 0.0 110.326 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -104.37 97.96 6.24 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.284 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.25 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.514 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.3 m -75.49 129.5 37.37 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -96.99 -56.35 2.58 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.948 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.17 97.77 8.55 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.88 -52.24 60.88 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.941 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -57.34 -25.16 58.96 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 126.425 1.89 . . . . 0.0 113.234 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -70.6 -30.56 67.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.297 1.046 . . . . 0.0 109.444 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 64.3 m -97.98 -42.34 7.56 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.607 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.6 -173.32 20.15 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.81 33.7 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.712 0.292 . . . . 0.0 110.916 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 69.39 23.59 6.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.219 1.408 . . . . 0.0 112.016 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.33 118.3 23.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.564 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.5 m -100.8 140.62 34.82 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 tt -126.76 109.78 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 70.88 19.4 5.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.442 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 -20.91 45.65 Favored Glycine 0 C--O 1.236 0.226 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.11 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.3 mt -89.19 127.81 41.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 m -81.99 109.64 16.51 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -101.32 126.05 35.82 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.21 130.78 33.45 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.385 2.723 . . . . 0.0 111.164 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 33.0 tpp -128.39 156.79 42.58 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.1 tt -118.77 -66.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 123.484 0.49 . . . . 0.0 111.892 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.996 0 O-C-N 121.714 -0.616 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.802 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 60.3 m -100.46 137.37 38.97 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -80.05 -55.96 4.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.262 0.553 . . . . 0.0 109.556 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -136.2 106.09 6.25 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.167 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.29 -46.81 85.02 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.17 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -60.19 -29.65 68.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.823 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.34 -44.4 75.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.63 0.729 . . . . 0.0 109.922 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.5 m -77.48 -39.57 46.0 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.804 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.36 165.34 12.06 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.41 142.86 35.57 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 69.12 25.25 5.84 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.545 1.138 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.33 149.61 22.25 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.4 143.18 45.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.3 m -106.54 133.54 51.07 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.393 0.616 . . . . 0.0 110.624 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 tt -145.31 114.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 63.28 23.47 13.83 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.753 1.221 . . . . 0.0 112.106 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.99 69.92 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -100.55 124.09 53.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.9 m -89.6 109.96 20.87 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.86 129.28 6.77 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.52 168.76 14.32 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.11 1.873 . . . . 0.0 111.408 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.8 ttp -92.44 152.33 19.75 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 mp -96.04 -78.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.107 0 O-C-N 122.199 -0.313 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 14' ' ' CYS . . . . . . . . 0 C--O 1.242 0.694 0 CA-C-O 121.336 0.588 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.5 m -88.0 157.26 18.96 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 34.9 mtmm -79.95 -55.5 4.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 45.0 mm-40 -117.57 156.27 28.38 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -70.44 -59.09 3.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.772 0.796 . . . . 0.0 111.394 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -60.94 -15.19 28.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.602 1.161 . . . . 0.0 112.646 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.7 tt0 -55.68 -41.62 73.97 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 124.841 1.257 . . . . 0.0 110.334 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.0 m -106.55 -30.46 9.03 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.536 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.95 -165.47 12.04 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.85 132.53 33.8 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 120.644 0.259 . . . . 0.0 111.096 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 70.04 16.42 7.55 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.142 1.377 . . . . 0.0 114.549 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.94 142.57 27.89 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -95.34 115.65 27.71 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.4 m -100.42 126.66 46.84 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.3 -175.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.3 mt -113.19 104.84 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.569 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 65.44 25.13 11.94 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 125.486 1.514 . . . . 0.0 111.854 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.2 -8.75 57.46 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.214 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 81.3 mt -92.01 134.17 31.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.39 114.9 22.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.228 0.537 . . . . 0.0 109.934 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.96 144.84 44.1 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.91 134.27 63.09 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.108 1.872 . . . . 0.0 111.335 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 53.0 ttm -78.35 145.3 35.32 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.142 0.496 . . . . 0.0 110.286 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -113.93 88.46 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.756 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.563 0 CA-C-N 116.129 -0.487 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.535 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.2 m -94.37 144.01 25.91 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -78.14 -55.82 4.96 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.408 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.35 140.12 39.33 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -54.61 -52.73 61.3 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.322 1.449 . . . . 0.0 111.258 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -63.54 -23.77 67.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.604 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.93 -26.89 62.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.155 0.979 . . . . 0.0 109.831 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 58.5 m -102.34 5.04 39.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.399 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.24 -81.56 1.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.71 175.83 5.27 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.98 118.3 7.62 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 33.0 tp -136.66 162.36 33.38 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -82.66 137.42 34.48 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 57.3 m -114.07 142.36 46.29 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.72 110.51 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 62.61 25.79 15.32 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.63 -15.05 56.18 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.083 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 70.9 mt -89.26 117.42 32.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.75 109.23 15.96 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.85 125.31 38.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.62 135.55 56.14 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.659 2.906 . . . . 0.0 111.683 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 53.0 ttp -69.35 144.34 53.48 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.285 0.564 . . . . 0.0 109.719 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.4 mm -98.76 97.73 6.34 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.146 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 CA-C-N 116.463 -0.335 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 120.53 0.205 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 84.9 m -70.96 131.78 44.22 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.33 -54.14 7.58 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -82.14 95.92 7.65 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -74.63 -44.14 51.98 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.925 -176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -59.93 -25.63 65.32 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.099 -1.41 . . . . 0.0 112.268 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -68.78 -18.5 64.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.788 0.804 . . . . 0.0 110.312 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 12' ' ' LEU . 59.6 m -98.02 -1.59 42.25 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.666 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.79 -149.12 29.57 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.216 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.58 111.33 22.89 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.803 0.302 . . . . 0.0 111.518 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 50.01 80.89 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.14 1.376 . . . . 0.0 113.772 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 17.0 tp -131.07 136.88 48.82 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 86.9 m-85 -82.75 154.75 24.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.487 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.4 m -100.97 132.12 46.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.406 ' HB ' HG12 ' A' ' 20' ' ' VAL . 45.7 mm -137.69 117.53 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 65.93 19.52 11.26 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 125.404 1.482 . . . . 0.0 112.074 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.7 -8.9 60.14 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.491 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.7 mt -115.54 145.44 21.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 67.4 m -83.89 129.49 34.93 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.121 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.406 HG12 ' HB ' ' A' ' 15' ' ' ILE . 14.5 p -142.03 141.04 20.55 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.99 143.62 66.7 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.25 1.967 . . . . 0.0 112.657 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.67 139.91 31.7 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -104.08 93.54 2.68 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.885 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.159 -173.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.565 0 CA-C-N 116.152 -0.476 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.6 m -77.54 146.32 36.39 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -75.14 -55.24 5.93 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.026 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.76 107.23 7.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 53.1 t80 -62.3 -45.49 92.99 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.984 -175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -57.7 -34.32 69.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.393 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.97 -28.42 64.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.577 0.751 . . . . 0.0 111.065 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 62.2 m -74.95 -18.49 60.38 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.268 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 -157.35 16.55 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.35 113.92 27.02 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.598 0.199 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 76.6 t80 63.92 95.45 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.106 1.362 . . . . 0.0 113.724 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 11' ' ' PHE . 3.7 mm? -132.73 160.44 36.8 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -106.64 149.8 26.85 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.1 m -101.14 132.87 46.41 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 120.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.77 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.345 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 68.22 19.99 8.95 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.643 1.577 . . . . 0.0 111.187 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.37 6.19 74.6 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.7 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.04 144.32 23.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.0 m -83.05 109.78 17.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.92 134.89 25.7 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.79 158.03 31.46 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.673 1.582 . . . . 0.0 110.155 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.5 tpt -87.53 150.58 23.63 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 tp -106.14 90.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 121.548 0.689 . . . . 0.0 110.844 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.192 0 CA-C-N 116.111 -0.495 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.428 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . . . . . . 0 N--CA 1.444 -0.753 0 CA-C-O 120.998 0.428 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.446 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 60.7 m -90.66 145.89 24.47 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 172.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.28 -56.17 25.35 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.402 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -107.9 80.92 1.43 Allowed 'General case' 0 N--CA 1.414 -2.269 0 CA-C-O 122.816 1.293 . . . . 0.0 111.545 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -64.49 -45.69 86.21 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.853 -174.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -65.43 -25.34 67.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.137 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -84.07 -50.98 7.47 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.538 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.402 ' SG ' ' HG2' ' A' ' 4' ' ' GLU . 54.5 m -71.96 -42.96 65.94 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.626 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.51 159.3 25.77 Favored Glycine 0 C--O 1.254 1.392 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.577 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.94 4.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.942 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 179.22 -32.36 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 125.192 1.397 . . . . 0.0 107.501 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.02 149.32 27.03 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.036 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.49 146.34 24.16 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.1 m -101.36 120.73 40.72 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -132.88 111.28 16.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 65.84 22.63 11.42 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.266 1.426 . . . . 0.0 111.04 -176.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 1' ' ' ALA . . . 88.79 -6.77 83.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.807 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.82 135.73 25.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 2' ' ' CYS . 20.1 m -82.02 110.0 16.87 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.38 152.08 77.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.412 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.98 145.64 25.11 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.872 1.714 . . . . 0.0 108.372 170.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.2 ttp -86.72 149.05 25.15 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.051 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.8 tt -130.42 94.7 2.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.607 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.204 0 O-C-N 121.968 -0.457 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.844 0.354 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.1 m -81.4 123.45 28.57 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -77.9 -55.21 5.5 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.49 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -118.45 141.86 48.14 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -93.12 -48.76 6.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -50.28 -44.66 53.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.53 1.532 . . . . 0.0 113.638 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.58 -26.15 63.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.124 0.964 . . . . 0.0 110.596 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.485 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 59.4 m -92.64 -30.68 15.47 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.005 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.32 -146.48 18.15 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.38 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.49 122.04 46.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 60.42 101.01 0.02 OUTLIER 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.84 1.256 . . . . 0.0 111.135 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -135.36 162.95 31.16 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.356 -175.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.66 141.68 44.96 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 12' ' ' LEU . 76.0 m -116.66 138.35 51.51 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.64 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.43 106.03 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.184 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 63.34 26.32 14.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.187 1.395 . . . . 0.0 112.317 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 1' ' ' ALA . . . 99.66 -17.77 57.05 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.376 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.38 132.27 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.1 m -98.92 150.02 22.35 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.029 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.03 120.17 30.44 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.61 165.33 27.81 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.461 2.108 . . . . 0.0 113.277 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -53.16 141.57 22.86 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.439 1.095 . . . . 0.0 110.453 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.6 mt -106.58 97.3 5.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.15 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.495 0 CA-C-N 116.252 -0.431 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.94 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.7 m -73.18 122.07 21.3 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.4 -55.39 4.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -104.63 89.43 3.19 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -79.09 -38.74 35.52 Favored 'General case' 0 C--N 1.261 -3.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.962 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -52.81 -33.91 51.35 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.783 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.28 -31.33 65.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.613 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.2 m -81.35 -41.26 22.28 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.39 161.53 14.57 Favored Glycine 0 N--CA 1.417 -2.575 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.058 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.52 126.28 28.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 80.8 7.57 1.3 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.119 1.368 . . . . 0.0 113.165 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 12' ' ' LEU . 20.4 tp -94.31 101.78 13.75 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.7 153.79 25.15 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.268 -171.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 56.6 m -100.13 127.87 46.3 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -124.64 110.45 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 67.87 23.06 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.704 1.602 . . . . 0.0 109.8 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.29 -20.52 42.41 Favored Glycine 0 C--N 1.309 -0.965 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.022 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 48.3 mm -96.19 138.69 20.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.0 m -81.16 108.99 15.28 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.05 125.16 30.69 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.516 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.6 135.1 15.88 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.127 1.884 . . . . 0.0 111.102 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.98 157.6 34.71 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.0 mt -86.64 99.28 7.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 120.935 0.398 . . . . 0.0 110.265 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 116.393 -0.367 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m -77.88 149.99 34.2 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.96 -42.11 9.64 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 40.5 mt-10 -107.75 115.63 30.5 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -53.9 -49.56 68.33 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.869 0.842 . . . . 0.0 111.166 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.477 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 37.7 p90 -63.4 -9.88 14.37 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.945 -1.48 . . . . 0.0 114.349 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.63 -56.7 12.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.552 0.691 . . . . 0.0 110.818 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.48 -25.83 5.93 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.222 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.13 152.64 15.25 Favored Glycine 0 C--O 1.247 0.925 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -174.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.72 93.61 8.48 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.606 0.717 . . . . 0.0 110.6 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -172.96 -45.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.45 162.9 17.02 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 71.3 m-85 -98.32 168.76 10.02 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 m -138.61 120.42 15.34 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.348 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.477 HG23 ' HB ' ' A' ' 18' ' ' ILE . 10.2 tt -98.28 91.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 CA-C-O 122.786 1.279 . . . . 0.0 108.234 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.19 28.09 17.64 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.514 -2.13 . . . . 0.0 112.056 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.99 -16.01 23.18 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.443 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 15' ' ' ILE . 50.9 mm -86.74 133.49 29.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -81.76 131.28 35.26 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.06 0.457 . . . . 0.0 110.355 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 13' ' ' PHE . 61.6 t -99.74 123.44 47.68 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.96 134.95 67.23 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.543 2.829 . . . . 0.0 113.979 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.6 tpt -81.1 144.96 31.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.429 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.3 89.03 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.688 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 116.236 -0.438 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 56.8 m -100.17 153.78 18.98 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -56.9 -39.55 74.61 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 7' ' ' GLU . 9.4 tp10 -165.79 146.6 6.84 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 168.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -77.92 -53.28 7.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.577 0.703 . . . . 0.0 111.547 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -68.82 -26.19 65.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 9.4 pt-20 -72.16 -27.68 62.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.401 0.62 . . . . 0.0 110.868 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.2 m -83.57 -39.4 20.42 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.507 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.29 -146.25 18.21 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.3 122.37 46.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 57.29 82.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.906 1.282 . . . . 0.0 114.088 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.65 131.62 53.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.43 118.08 24.74 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 60.2 m -100.83 144.87 29.26 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.831 -171.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.2 mt -139.5 121.3 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 68.59 22.18 7.71 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.397 1.479 . . . . 0.0 109.772 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -15.98 59.89 Favored Glycine 0 C--N 1.305 -1.158 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.705 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.42 131.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 58.0 m -81.36 109.63 16.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.58 110.76 62.66 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.144 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.68 160.63 19.13 Favored 'Trans proline' 0 N--CA 1.432 -2.137 0 C-N-CA 121.766 1.644 . . . . 0.0 110.999 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 55.0 ttp -61.47 155.7 21.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.08 91.3 3.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.098 0 CA-C-N 116.102 -0.499 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 80.3 m -81.78 147.45 29.41 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 123.162 0.288 . . . . 0.0 110.676 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -79.75 -33.49 40.68 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.286 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -73.8 78.37 1.59 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.325 1.06 . . . . 0.0 112.055 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -72.17 -44.1 63.57 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.09 -1.413 . . . . 0.0 108.251 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -60.05 -35.05 74.28 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.59 -49.41 12.23 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.23 -42.24 55.74 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.075 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.09 -170.43 15.03 Favored Glycine 0 C--N 1.299 -1.499 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 95.16 1.47 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 60.47 85.77 0.11 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.38 156.47 23.4 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 22' ' ' MET . 82.8 m-85 -100.12 163.75 12.28 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.6 m -123.33 137.6 54.8 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.162 -1.015 . . . . 0.0 113.507 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.27 105.03 13.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 66.34 22.12 10.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 126.314 1.845 . . . . 0.0 110.534 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.82 -7.55 63.06 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.918 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mm -87.08 125.41 40.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 79.3 m -81.3 121.6 26.39 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.461 0.476 . . . . 0.0 110.261 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.54 160.09 66.6 Favored Pre-proline 0 C--N 1.305 -1.339 0 C-N-CA 124.033 0.933 . . . . 0.0 108.987 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.32 137.97 49.27 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.483 1.456 . . . . 0.0 109.022 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.565 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . 54.6 ttp -63.4 135.53 57.02 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.981 0.896 . . . . 0.0 112.593 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -94.29 98.91 8.67 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.528 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.569 0 CA-C-N 116.549 -0.296 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.273 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 73.6 m -72.98 144.82 47.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.786 0.327 . . . . 0.0 110.735 -178.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -77.56 -42.62 34.67 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -89.88 88.25 7.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.254 176.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 11' ' ' PHE . 26.3 t80 -85.2 -27.81 25.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -61.18 -25.25 66.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.646 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.35 -33.14 69.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.95 0.881 . . . . 0.0 109.484 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 59.3 m -76.19 -43.42 42.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.527 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.76 -148.1 18.91 Favored Glycine 0 C--N 1.298 -1.53 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.42 105.91 17.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.065 -178.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 97.7 m-85 65.45 86.61 0.13 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.692 1.197 . . . . 0.0 114.094 175.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 3.7 mm? -136.39 162.91 31.73 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.215 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -108.25 154.02 22.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.59 139.22 50.75 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.391 0.615 . . . . 0.0 111.699 -178.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.3 tt -140.19 108.97 3.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.278 175.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 61.38 26.94 16.64 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.105 1.362 . . . . 0.0 112.071 178.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.81 -9.85 64.13 Favored Glycine 0 C--N 1.313 -0.713 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.187 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.12 128.38 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.0 m -87.59 118.06 26.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.0 m -120.99 140.06 30.27 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.591 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 20' ' ' VAL . 14.2 Cg_exo -69.51 116.54 4.58 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 122.38 2.053 . . . . 0.0 110.958 175.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -98.98 156.39 16.94 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 tt -116.03 92.72 2.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.75 0.786 . . . . 0.0 110.501 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 115.87 -0.604 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_